prednisolone has been researched along with Colitis, Granulomatous in 372 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under steroids and azathioprine." | 8.90 | Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review. ( Abreu, C; Andrade, P; Coelho, R; Lopes, S; Macedo, G; Magro, F; Santos-Antunes, J; Vilas-Boas, F, 2014) |
| " Two young adult women are described in whom headache and papilloedema in association with raised intracranial pressure occurred during prednisolone treatment for inflammatory bowel disease." | 7.69 | Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. ( Cooper, BT; Newton, M, 1994) |
| "The combination of cyclosporine, azathioprine and low-dose prednisolone leads to marked improvement of perianal fistulas in Crohn's disease." | 7.69 | Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. ( Aichbichler, B; Fickert, P; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Ranner, G, 1997) |
| " We report a case of disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under steroids and azathioprine." | 4.90 | Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review. ( Abreu, C; Andrade, P; Coelho, R; Lopes, S; Macedo, G; Magro, F; Santos-Antunes, J; Vilas-Boas, F, 2014) |
| " Because the patient was allergic to mesalazine, adalimumab (ADA) was used as maintenance therapy during pregnancy, following prednisolone as remission induction therapy." | 3.79 | Maintenance of the remission stage of Crohn's disease with adalimumab therapy during pregnancy. ( Ebi, M; Joh, T; Kamiya, T; Katano, T; Kataoka, H; Mizoshita, T; Mori, Y; Ozeki, K; Tanida, S; Tsukamoto, H, 2013) |
| "Pellagra is a nutritional disease caused by the deficiency of niacin." | 3.78 | Letter: Pellagra as the initial presentation of Crohn disease. ( Fernandes, IC; Oliveira, A; Pinto-Almeida, T; Rosmaninho, A; Sanches, M; Selores, M; Vilaça, S, 2012) |
| "Reported herein is a case of hepatocellular carcinoma (HCC) occurring in a 25-year-old Japanese man who was diagnosed with Crohn's disease (CD) at 14 years of age; treatment included predonisolone, azathioprine, and infliximab." | 3.75 | Hepatocellular carcinoma occurring in a young Crohn's disease patient. ( Enaka, M; Kawachi, K; Kunisaki, R; Morimoto, M; Murakami, A; Nagano, Y; Nozawa, A; Sasaki, T; Tanabe, M; Tanaka, Y; Ueda, M, 2009) |
| " Two young adult women are described in whom headache and papilloedema in association with raised intracranial pressure occurred during prednisolone treatment for inflammatory bowel disease." | 3.69 | Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. ( Cooper, BT; Newton, M, 1994) |
| "The combination of cyclosporine, azathioprine and low-dose prednisolone leads to marked improvement of perianal fistulas in Crohn's disease." | 3.69 | Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. ( Aichbichler, B; Fickert, P; Hinterleitner, TA; Krejs, GJ; Petritsch, W; Ranner, G, 1997) |
| "To characterise the REE and body composition in children with Crohn's disease and compare them with normal controls and patients with anorexia nervosa; to compare the effects of prednisolone and enteral nutrition on energy expenditure and body composition." | 3.69 | Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. ( Azcue, M; Griffiths, A; Pencharz, PB; Rashid, M, 1997) |
| " Low birth weight were observed after the medication of prednisolone and a manifestation of the ulcerous colitis during the gravidity." | 3.68 | [Pregnancy and chronic inflammatory bowel diseases]. ( Hänert, E; Schneider, W, 1991) |
| "The effect of intestinal malabsorption on the oral bioavailability of prednisolone has been studied in six patients with celiac disease and in six patients with malabsorption of various etiologies, five of whom had undergone gut resections." | 3.66 | Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding. ( Bergrem, H; Opedal, I, 1983) |
| "Vidofludimus (SC12267) is a novel oral immunomodulator inhibiting dihydroorotate dehydrogenase (DHODH) and the expression of proinflammatory cytokines including interleukin-17 (IL17A and IL17F) and interferon-gamma." | 2.78 | Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. ( Ammendola, A; Diculescu, M; Dietrich, B; Fellermann, K; Hartmann, H; Hentsch, B; Herrlinger, KR; Howaldt, S; Nikolov, R; Otte, JM; Petrov, A; Reindl, W; Stange, EF; Stoynov, S; Strauch, U; Sturm, A; Voiosu, R, 2013) |
| "Patients with Crohn's disease (CD) often develop malnutrition due to disease activity." | 2.73 | Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone. ( Brandslund, I; Eivindson, M; Grønbaek, H; Hey, H; Munkholm, P; Nielsen, AA; Nielsen, JN; Vind, I, 2007) |
"Those in remission (Crohn's Disease Activity Index | 2.73 | Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. ( Connell, W; Crotty, B; Ee, H; Florin, T; Gibson, P; Hetzel, D; Merrett, M; Mitchell, B; Pavli, P; Radford-Smith, G; Read, R; Selby, W, 2007) | |
| " Patients received either two infusions of infliximab (5 mg/kg) alone (n=8) or in combination with long-term methotrexate at a dosage of 20 mg/week (n=11) over 48 weeks." | 2.72 | Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. ( Blumenstein, I; Schröder, O; Stein, J, 2006) |
| "Prednisolone/placebo was tapered after week 1, and patients were assessed every second week." | 2.72 | Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease. ( Boerner, N; Bokemeyer, B; Emmrich, J; Herrlinger, KR; Krummenerl, T; Kueppers, B; Mescheder, A; Raedler, A; Schulzke, JD; Schwertschlag, U; Shapiro, M; Stange, EF; Witthoeft, T, 2006) |
| "Budesonide is a corticosteroid with low systemic bioavailability because of its high first-pass metabolism in the liver." | 2.71 | Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial. ( Escher, JC, 2004) |
| "Fifteen patients with active Crohn's disease and 19 controls with inactive Crohn's disease were recruited." | 2.71 | Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy. ( Greenwood, R; Probert, CS; Sasi, MR; Tobias, JH, 2004) |
| "Osteoporosis frequently occurs in Crohn's disease, often because of corticosteroids." | 2.71 | Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. ( Bianchi Porro, G; Bollani, S; Felsenberg, D; Graffner, H; Haptén-White, L; Israeli, E; Ljunghall, S; Mills, PR; Persson, T; Schoon, EJ; Stockbrügger, RW; Vatn, M, 2005) |
| "Patients with corticosteroid-dependent Crohn's disease (use of prednisolone 15-40 mg/day or budesonide 9 mg/day for at least 8 weeks, a previous failed attempt to discontinue corticosteroids within 8 weeks, and Crohn's Disease Activity Index score 150 points or less) were enrolled in a 16-week, randomized, double-blind, placebo-controlled trial." | 2.71 | A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. ( Archambault, A; Baker, JP; Bernstein, CN; Cameron, S; Cominelli, F; Elson, CO; Feagan, BG; Hanauer, SB; Heath, PK; Lichtenstein, GR; Salzberg, BA; Sandborn, WJ; Sutherland, LR, 2005) |
| "Crohn's disease is a chronic inflammatory condition affecting the gastrointestinal tract." | 2.71 | Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. ( Brandslund, I; Eivindson, M; Grønbaek, H; Hey, H; Hougaard, DM; Jensen, S; Jørgensen, LG; Munkholm, P; Nielsen, AA; Nielsen, JN; Skogstrand, K; Vind, I, 2005) |
| "Prednisolone was tapered to zero during the first 4-10 weeks and budesonide or placebo was given concomitantly and for a further 12 weeks." | 2.70 | Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease. ( Colombel, JF; Cortot, A; Hämling, J; Lauritsen, K; Malchow, H; Persson, T; Pettersson, E; Rutgeerts, P; Winter, T, 2001) |
| "Prednisolone was withdrawn gradually." | 2.70 | Does adjuvant nutritional support diminish steroid dependency in Crohn disease? ( Giaffer, MH; Holdsworth, CD; Verma, S, 2001) |
| "Some patients with Crohn's disease (CD) do not respond to corticosteroid therapy." | 2.70 | Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease. ( Andus, T; Bregenzer, N; Gelbmann, CM; Gierend, M; Gross, V; Rogler, G; Schölmerich, J, 2002) |
| "Azathioprine is an effective agent in the management of chronic active Crohn's disease leading to long term remission of disease activity." | 2.69 | Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. ( Krummenauer, F; Meyer zum Büschenfelde, KH; Neurath, MF; Peters, M; Schlaak, JF; Wanitschke, R, 1999) |
| "Sixty three patients with active Crohn's disease were treated with a 12 weeks diminishing dose of prednisolone and at the same time entered into a randomised, double blind 15 month trial of either azathioprine (2." | 2.68 | A controlled double blind study of azathioprine in the management of Crohn's disease. ( Adams, G; Candy, S; Gerber, M; Gerig, M; Goodman, R; Wright, J, 1995) |
| "One hundred fifty patients with active Crohn's disease were administered oral prednisolone (1 mg." | 2.68 | Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. ( Belaïche, J; Cadiot, G; Colombel, JF; Costil, V; Danne, O; Dapoigny, M; Duclos, B; Dupas, JL; Galmiche, JP; Gendre, JP; Lamouliatte, H; Mary, JY; Modigliani, R; Soulé, JC; Veyrac, M, 1996) |
| "3." | 2.68 | Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment. ( Cassell, TB; Dowling, RH; Engelman, JL; Murphy, GM; Pereira, SP; Sladen, GE, 1996) |
| "Sixteen Crohn's disease patients received oxpentifylline 400 mg four times a day in a four week open label study." | 2.68 | Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease. ( Bauditz, J; Haemling, J; Lochs, H; Ortner, M; Raedler, A; Schreiber, S, 1997) |
| " Budesonide is a potent corticosteroid with low systemic bioavailability due to an extensive first pass liver metabolism." | 2.68 | Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group. ( Campieri, M; Doe, W; Ferguson, A; Nilsson, LG; Persson, T, 1997) |
| "In all patients studied, simple Crohn's disease activity index, nutritional status (expressed as body mass index), percentage of ideal body weight, fat mass, fat free mass, erythrocyte sedimentation rate, interleukin-6, intestinal permeability (expressed as permeability index), prealbumin, retinol binding protein and multiskin test were evaluated before and after treatment." | 2.68 | A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease. ( Bernardi, M; Biagi, PL; Carè, M; Gasbarrini, G; Parazza, M; Spanò, C; Zoli, G, 1997) |
| "Therefore we are convinced that in Crohn's disease parts of the intestinal microflora, including the host's immune response toward indigenous flora or an impairment of the gut flora's metabolic activity are involved in the development or at least in the onset of relapse from remissive of colonic Crohn's disease." | 2.68 | Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? ( Malchow, HA, 1997) |
| "Twenty nine children with Crohn's disease were studied before and after treatment with steroids or an elemental diet to assess the effect of disease activity and treatment on serum insulin like growth factor I (IGF-I), insulin like growth factor binding protein (IGFBP-1), and insulin concentrations." | 2.67 | Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. ( Holly, JM; Miller, V; Taylor, F; Thomas, AG, 1993) |
| "The activity of Crohn's disease was similar in both groups before the commencement of the treatment." | 2.67 | Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. ( Mäki, M; Ormälä, T; Ruuska, T; Savilahti, E; Visakorpi, JK, 1994) |
| "The etiology of Crohn's disease remains unknown, but current research has concentrated on autoimmunity and/or mycobacterial infection." | 2.67 | Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction. ( Andersen, J; Binder, V; Engbaek, K; Lisby, G, 1994) |
| "Childhood Crohn's disease may cause significant morbidity." | 2.67 | Cyclosporin as initial treatment for Crohn's disease. ( Braegger, CP; Dawnay, A; Domizio, P; MacDonald, TT; Nicholls, S; Walker-Smith, JA; Williams, CB, 1994) |
| " Budesonide is a potent, well-absorbed corticosteroid, but because of a high rate of first-pass metabolism in the liver, its systemic bioavailability is low." | 2.67 | A comparison of budesonide with prednisolone for active Crohn's disease. ( Danielsson, A; Goebell, H; Jewell, D; Lamers, C; Löfberg, R; Lorenz-Meyer, H; Malchow, H; Olaison, G; Rutgeerts, P; Thomsen, OO, 1994) |
| "Serial measurements of body weight and Crohn's disease activity index (CDAI) together with blood values for albumin, haemoglobin, white cell count, and platelets showed no consistent different differences between groups." | 2.67 | Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease. ( Lawrie, BW; Newcombe, RG; Pullan, RD; Rhodes, J; Rhodes, P; Roberts, G; Srivastava, ED; Stone, R; Swift, GL; Wilkinson, S, 1994) |
| "Thirty two patients with active Crohn's disease were included in a controlled randomised trial to determine the efficacy and safety of polymeric enteral nutrition compared with steroids, to achieve and maintain clinical remission." | 2.67 | Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. ( Abad-Lacruz, A; Acero, D; Cabré, E; de León, R; Esteve, M; Fernández-Bañares, F; Figa, M; González-Huix, F; Guilera, M; Planas, R, 1993) |
| " This study examined whether AZA combined with standard prednisolone therapy improved the therapeutic outcome compared with monotherapy with prednisolone." | 2.67 | Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. ( Ewe, K; Hommel, G; Meyer zum Büschenfelde, KH; Press, AG; Singe, CC; Stufler, M; Ueberschaer, B, 1993) |
| "Forty two patients with active Crohn's disease were stratified for nutritional state and randomised to receive Vivonex TEN 2." | 2.67 | Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. ( Clark, ML; Farthing, MJ; Gorard, DA; Hunt, JB; Misiewicz, JJ; Palmer, KR; Payne-James, JJ; Rees, RG; Silk, DB, 1993) |
| "day-1; 136 achieved clinical remission, but 96 of them still had active endoscopic lesions and were randomized either to immediate start of steroid tapering (group A; n = 46) or to continued prednisolone treatment at the same dosage for 5 more weeks before steroid tapering was begun (group B; n = 50)." | 2.67 | Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. ( Anh, TN; Bories, P; Cortot, A; Florent, C; Gendre, JP; Landi, B; Metman, EH; Rene, E; See, A; Soule, JC, 1992) |
| "130 patients with Crohn's disease were colonoscopied in a multicenter trial." | 2.66 | European Cooperative Crohn's Disease Study (ECCDS): colonoscopy. ( Brandes, JW; Lorenz-Meyer, H; Malchow, H; Miller, B; Stock, H, 1985) |
| "26 in-patients (17 with Crohn's disease, 9 with ulcerative colitis) were given high-molecular (diet 1; 12 patients) or low-molecular (diet 2; 14 patients) elemental diets (6." | 2.66 | [Adjuvant therapy with elemental diet in chronic inflammatory intestinal diseases. Comparative study]. ( Heskamp, R; Rabast, U, 1986) |
| " However, oral dosage of the drug is difficult and regular determinations of the trough blood concentration are indispensable." | 2.66 | [Cyclosporin A in acute Crohn disease: initial findings]. ( Gyr, K; Marbet, UA; Stalder, GA, 1986) |
| "Patients were assessed using the Crohn's disease activity index (CDAI), ESR, and faecal granulocyte excretion quantified by 111In-autologous leucocytes." | 2.66 | Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. ( Chadwick, VS; Hodgson, HJ; Saverymuttu, S, 1985) |
| "Acute exacerbations of Crohn's disease are usually treated with prednisolone or potentially more toxic immunosuppressive drugs or by surgery." | 2.65 | Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. ( Levi, AJ; O'Moráin, C; Segal, AW, 1984) |
| "This might mean that patients with Crohn's disease undergoing an early operation have a better chance of escaping recurrences." | 2.64 | Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease. ( Bergman, L; Krause, U, 1976) |
| "In the case of steroid resistance in ulcerative colitis, aminosalicylates, the above-mentioned immunomodulators, infliximab, adalimumab or calcineurin inhibitors such as ciclosporin or tacrolimus may be administered." | 2.48 | Therapy of steroid-resistant inflammatory bowel disease. ( Frei, P; Lakatos, PL; Manz, M; Rogler, G; Safroneeva, E; Schoepfer, AM; Vavricka, SR; Wanner, R, 2012) |
| "Takayasu's arteritis (TA) and Crohn's disease (CD) are chronic inflammatory diseases of uncertain etiology." | 2.47 | Rare case of Takayasu's arteritis associated with Crohn's disease. ( Amano, Y; Fukuba, N; Ishihara, S; Kinoshita, Y; Kusunoki, R; Mishima, Y; Moriyama, I; Murakawa, Y; Oka, A; Okada, M; Oshima, N; Sato, M; Sato, S; Sumita, Y; Tada, Y; Yuki, T, 2011) |
| "Crohn's disease and ulcerative colitis are the most frequent inflammatory bowel diseases (IBD) with a prevalence of approximately one out of 500." | 2.42 | [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy]. ( Göke, B; Ochsenkühn, T; Sackmann, M, 2003) |
| "In the cases of Crohn's disease and rheumatoid arthritis administered anti-TNF-alpha, chemoprophylaxis is necessary for those who show healing of TB despite those who are suspected of having TB infection by a tuberculin test." | 2.42 | [Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis]. ( Yamagishi, F, 2003) |
| " Oral steroid dosage had slowly been tapered over 1 month." | 2.42 | Pulmonary involvement in Crohn's disease report of a case and review of the literature. ( Asahi, H; Inoue, Y; Irinoda, T; Omori, H; Saito, K, 2004) |
| "It describes the treatment of ulcerative colitis according to the different groups of patients and the degree of activity." | 2.41 | [Conservative therapy of inflammatory bowel diseases]. ( Nagy, F, 2002) |
| "The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission." | 2.41 | New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. ( Campieri, M, 2002) |
| "The association of Sweet's syndrome and Crohn's disease is rare." | 2.39 | [Sweet syndrome associated with Crohn disease]. ( Beylot, C; Beylot-Barry, M; Beyssac, R; Doutre, MS; Ly, S, 1995) |
| "The reported incidence of Crohn's disease has increased in the last 30 years." | 2.37 | Chronic inflammatory bowel disease. ( Sanderson, IR, 1986) |
| "A 23-year-old man diagnosed with Crohn's disease (CD) was treated with infliximab." | 1.91 | Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease. ( Abe, K; Funakoshi, S; Hirai, F; Imakiire, S; Ishibashi, H; Ishida, Y; Ko, YL; Kuno, N; Matsuoka, H; Matsuoka, S; Miyagi, S; Nomaru, R; Sakata, T; Sakisaka, H, 2023) |
| "001), with increases in poorly bioavailable oral corticosteroids in Crohn's (pandemic 15." | 1.72 | Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study. ( Bhala, N; Brookes, MJ; Conley, TE; Gonzalez, HA; Hicks, LC; Kennedy, NA; Kent, AJ; Lamb, CA; Mehta, SJ; Patel, KV; Saifuddin, A; Sebastian, S; Segal, JP; Subramanian, S; Walker, GJ, 2022) |
| "Differentiating Crohn's disease (CD) from intestinal tuberculosis (TB) is a challenge." | 1.62 | Case of Crohn's Disease Initially Misdiagnosed as Intestinal Tuberculosis Due to Active Pulmonary Tuberculosis. ( Choi, S; Kim, D; Lee, T; Lim, W; Oh, H; Park, H; Park, S; Song, C; Yun, J, 2021) |
| "She was diagnosed with orofacial granulomatosis (OFG) and was treated conservatively for 7 years, with no evidence of systemic illness." | 1.42 | Orofacial granulomatosis as a presenting feature of Crohn's disease. ( Henson, S; Jennings, VC; Williams, L, 2015) |
| "Extraintestinal manifestations in Crohn's disease (CD) are frequent and well recognized." | 1.42 | Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report. ( Asaoka, K; Gekka, M; Kato, Y; Nishihara, H; Nomura, M; Sugiyama, T, 2015) |
| "She was diagnosed with Crohn's disease after undergoing colonoscopy and CT enterography." | 1.40 | [A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease]. ( Bae, GH; Kim, EJ; Kim, EY; Lee, HC; Lee, TS; Oh, HK; Song, JE, 2014) |
| "Oral prednisolone was administered, and serum creatinine level showed partial recovery." | 1.40 | A case of late onset-acute tubulointerstitial nephritis with infliximab and mesalazine treatment in a patient with Crohn's disease. ( Bak, YT; Chung, SY; Gu, DH; Ko, GJ; Kwon, YJ; Pyo, HJ; Won, NH; Yoo, YJ, 2014) |
| "A 33-year-old man was diagnosed with Crohn's disease in 2001, and treated with mesalazine and ranitidine." | 1.39 | [A case of drug-induced granulomatous interstitial nephritis during the long course of Crohn's disease]. ( Imakita, N; Itano, S; Mori, D; Nagayama, I; Takeji, M; Yamaguchi, Y; Yamauchi, A, 2013) |
| "She was diagnosed with Crohn's disease and right internal iliac vein thrombosis." | 1.37 | Internal iliac vein thrombosis in pediatric Crohn's disease. ( Baysoy, G; Besbas, N; Daar, G; Demir, H; Elmas, SA; Haliloğlu, M, 2011) |
| "Erythema nodosum is the most common form of septal panniculitis and the most frequent skin manifestation associated with inflammatory bowel disease, affecting up to 15% of Crohn's disease patients." | 1.37 | [Crohn's disease presenting with erythema nodosum as an early sign: a case report]. ( Chang, HK; Kang, SJ; Kim, JB; Kim, KJ; Moon, W; Park, MI; Park, MJ; Park, SJ, 2011) |
| "Kwashiorkor is one of the severe forms of protein-energy malnutrition." | 1.36 | Cutaneous presentation of kwashiorkor due to infantile Crohn's disease. ( Al Goufi, T; Al-Khenaizan, S; Al-Mubarak, L, 2010) |
| "She was diagnosed with cutaneous polyarteritis nodosa (PAN) associated with CD." | 1.35 | Cutaneous polyarteritis nodosa in a patient with Crohn's disease. ( Kinoshita, K; Komatsuda, A; Maki, N; Masai, R; Niitsu, H; Ohtani, S; Sageshima, M; Sawada, K; Togashi, M; Wakui, H, 2008) |
| "Lichen planus is an idiopathic inflammatory disease of the skin and mucous membranes." | 1.35 | Annular lichen planus in association with Crohn disease. ( Correia, S; Organ, V; Pereira, L; Serrão, VV; Vale, E, 2008) |
| "A total of 58 patients with ulcerative colitis (UC, N = 37) or Crohn's disease (CD, N = 21) together with 11 healthy controls were included in this study." | 1.35 | Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. ( Hanai, H; Hirayama, K; Iida, T; Iwaoka, Y; Kikuyama, M; Maruyama, Y; Nagata, S; Takai, K; Takeuchi, K; Watanabe, F; Yamada, M, 2008) |
| "As pneumonia was suspected antibiotic treatment with ceftriaxone was started as well as topical antimycotic therapy with amphotericin B." | 1.34 | [Methotrexate-induced pneumonitis in a woman with Crohn's disease]. ( Brechmann, T; Heyer, C; Schmiegel, W, 2007) |
| "Ulcerative colitis (UC) and Crohn's disease (CD) are characterized by intestinal inflammation mainly caused by a disturbance in the balance between cytokines and increased complement (C) activation." | 1.33 | Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. ( Baatrup, G; Dahlerup, JF; Grønbaek, H; Thorlacius-Ussing, O; Zimmermann-Nielsen, E, 2005) |
| "Systemic corticosteroid therapy for Crohn's disease is associated with increased risk for intra-abdominal or pelvic abscess." | 1.33 | Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease. ( Agrawal, A; Durrani, S; Ellis, A; Leiper, K; Morris, AI; Rhodes, JM, 2005) |
| " The introduction of infliximab has improved disease control, although a search for an optimum remittive dosing schedule is ongoing." | 1.33 | Treatment of vulval Crohn's disease with infliximab. ( Hudson, N; Lewis, FM; Preston, PW, 2006) |
| "Ten subjects with active ulcerative colitis and 13 subjects with active Crohn's disease were recruited." | 1.33 | Repeat planar white cell scanning to monitor short-term therapy of active inflammatory bowel disease: a methodological study and comparison with clinical scores and novel inflammatory markers. ( Britten, AJ; Dearing, M; Gordon, C; Heenan, S; Irwin, AG; Maxwell, JD; Poullis, A, 2006) |
| "She was given a diagnosis of Crohn's disease, erythema nodosum, and Hashimoto disease." | 1.33 | [A case of Turner syndrome complicated with Crohn's disease, erythema nodosum and Hashimoto disease]. ( Hamura, K; Iimura, M; Iizuka, BE; Karibe, T; Mochizuki, N; Noto, H; Shiratori, K; Takasaki, T; Tanishima, M; Torii, N, 2006) |
| "Intravenous pulse cyclophosphamide may be a safe and effective treatment in patients with severe IBD unresponsive to steroid treatment and merits evaluation in a controlled trial." | 1.32 | Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. ( Duchmann, R; Fischinger, J; Moser, C; Stallmach, A; Wittig, BM; Zeitz, M, 2003) |
| "We present the case of a patient with Crohn's disease under immunosuppressive therapy who developed a spontaneous covered spleen rupture in the course of a septic shock with DIG due to a Varizella zoster infection." | 1.32 | [Functional asplenia after severe varicella zoster-infection diagnosis by colour Doppler ultrasound]. ( Arnold, R; Diedrich, J; Eissele, R; Görg, C, 2003) |
| "Twenty-five patients with active Crohn's disease requiring systemic glucocorticoid treatment (prednisolone, 60 mg/day) were investigated." | 1.32 | Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. ( Adler, G; Brinskelle-Schmal, N; Epp, S; Hawa, G; Hofbauer, LC; Klaus, J; Kratzer, W; Mason, R; Reinshagen, M; von Tirpitz, C, 2003) |
| " The aim of our study was to review our data to determine if the steroid dosage is associated with the incidence of early complications after bowel resection in patients with prolonged steroid therapy for Crohńs disease (CD)." | 1.32 | Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohńs disease. ( Anthoni, C; Bruewer, M; Kersting, S; Krieglstein, CF; Laukoetter, MG; Rijcken, EJ; Senninger, N; Utech, M, 2003) |
| "The risk of colorectal cancer was not increased, either in the total group of patients or in patients with colonic Crohn's disease exclusively (standardized morbidity ratio, 1." | 1.32 | Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. ( Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV, 2004) |
| " A broncho-bronchiolitis associated with Crohn's disease was finally diagnosed despite the need for a differential diagnosis of mesalazine-induced disease due to the long-term administration of mesalazine before the onset of the pulmonary lesion." | 1.32 | [A case of Crohn's disease with broncho-bronchiolitis]. ( Hosogi, S; Iwasaki, Y; Kubota, Y, 2004) |
| "Twenty-six patients (14 ulcerative colitis, 12 Crohn's disease) were included." | 1.32 | Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. ( Bastida, G; Domènech, E; Esteve-Comas, M; Gassull, MA; Gomollón, F; Herrera, JM; Hinojosa, J; Obrador, A; Ruiz, R; Saro, C, 2004) |
| "In Crohn's disease, osteoporosis is frequently found." | 1.31 | Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? ( Corstens, FH; de Jong, DJ; Mannaerts, L; Naber, AH; van Rossum, LG, 2002) |
| "Retinal neovascularization was detected during the follow-up." | 1.31 | Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease. ( Durak, I; Ergin, MH; Koçak, N; Saatci, OA, 2001) |
| "We describe a patient with IgA nephropathy associated with Crohn disease." | 1.31 | An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. ( Kuwajima, H; Okada, M; Takemura, T; Yagi, K; Yanagida, H, 2002) |
| "Thirty-nine patients with IBD (22 with ulcerative colitis, 17 with Crohn's disease) and 35 normal controls were studied." | 1.31 | Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. ( Buttgereit, F; Lochs, H; Rohde, W; Schottelius, A; Schreiber, S; Wedel, S; Weltrich, R, 2000) |
| "Up to 50% of patients with Crohn's disease (CD) develop steroid-dependent or refractory disease requiring immunosuppression." | 1.31 | Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease? ( Gangl, A; Miehsler, W; Moser, G; Reinisch, W; Vogelsang, H, 2001) |
| " As a consequence of improved delivery of enteral nutrition, in the year after the insertion of the gastrostomy there was a reduction in prednisolone dosage in all patients, with six patients being able to stop prednisolone completely." | 1.30 | Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease. ( Cosgrove, M; Jenkins, HR, 1997) |
| "Blood was collected from patients with Crohn's disease (N = 49), ulcerative colitis (N = 43), and normal control volunteers (N = 15)." | 1.30 | Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease. ( Bernstein, CN; Rawsthorne, P; Rector, E; Sargent, M, 1997) |
| "Patients with Crohn's disease had significantly lower lumbar spine and total body BMD SDS than patients with ulcerative colitis, even after adjustment for cumulative dose of prednisolone." | 1.30 | Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. ( Boot, AM; Bouquet, J; de Muinck Keizer-Schrama, SM; Krenning, EP, 1998) |
| "In both IBDs, but particularly Crohn's disease, increased activation of NF kappa B may be involved in the regulation of the inflammatory response." | 1.30 | Activation of nuclear factor kappa B inflammatory bowel disease. ( Hampe, J; Nikolaus, S; Schreiber, S, 1998) |
| "Twenty-seven patients with active ulcerative colitis and 42 with active Crohn's disease treated with glucocorticoids were studied." | 1.30 | Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease. ( Brandslund, I; Kjeldsen, J; Lassen, JF; Schaffalitzky de Muckadell, OB, 1998) |
| "The simultaneous occurrence of Sweet's syndrome (SS) and erythema nodosum (EN) in 1 patient is rare." | 1.30 | Sweet's syndrome and erythema nodosum: the simultaneous occurrence of 2 reactive dermatoses. ( Billingsley, EM; Long, D; Marks, JG; Waltz, KM, 1999) |
| "Clinical activity was evaluated by the Crohn's disease activity index (CDAI) and serum IL-6 levels measured by enzyme-linked immunosorbent assay." | 1.30 | Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. ( Bakos, S; Dejaco, C; Gangl, A; Gasché, C; Lichtenberger, C; Lochs, H; Reinisch, W; Tillinger, W; Vogelsang, H; Waldhör, T; Willheim, M; Wyatt, J, 1999) |
| "A 53-year-old woman with moderate aplastic anemia (AA) was treated with antithymocyte globulin (ATG)." | 1.30 | [Moderate aplastic anemia associated with Crohn's disease during antithymocyte globulin treatment]. ( Akifuji, Y; Hatake, K; Miura, Y; Mori, M; Nakamoto, S; Ozawa, K; Tanaka, T; Terui, Y; Tomizuka, H; Ueki, J; Uwai, M, 1999) |
| " During the last 6 months prior to the study the patients had a median Crohn's disease activity index (CDAI) of 193 (interquartile range: 122-230) (monthly controls) with a median prednisolone dosage of 14 mg per day (9-20)." | 1.29 | Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study. ( Kleinberger, M; Lochs, H; Moser, G; Novacek, G; Vogelsang, H, 1995) |
| "Metastatic cutaneous Crohn's disease, in which noncaseating granulomatous infiltration of the skin occurs at sites separated from the gastrointestinal tract by normal tissue, is the least common dermatological manifestation of Crohn's disease." | 1.29 | Disseminated metastatic cutaneous Crohn's disease. ( Ferguson, A; Hunter, JA; McLaren, K; Peltz, S; Vestey, JP, 1993) |
| "In patients with Crohn's disease not taking corticosteroids, IgM lipocortin-I antibody levels were directly related to disease activity scored clinically." | 1.29 | Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. ( Rampton, DS; Smith, SF; Stevens, TR, 1993) |
| "Pancreatitis is generally regarded to be an extra-intestinal complication of Crohn's disease unless the duodenum is directly involved." | 1.29 | Crohn's disease associated with pancreatitis of unknown etiology: a case report. ( Arakawa, S; Omata, F; Takahashi, H; Ueno, F, 1993) |
| " Prednisolone dosage at start of therapy depended on initial inflammatory activity (CDAI)." | 1.29 | [Alpha-interferon therapy in Crohn's disease: initial clinical results]. ( Ammann, R; Jost, R; Meyenberger, C; Münch, R; Wirth, HP; Zala, G, 1993) |
| "Based on the improvement of Crohn's disease (CD) with elemental diets, we treated a patient with recurrent stenosing disease using prednisolone and drastic reduction of oral lipid intake." | 1.29 | Does exclusion of enteral lipid assist remission in Crohn's disease? ( Ali, S; Giles, A; Kaczmar, A; Roediger, WE, 1993) |
| "Crohn's disease is characterised by gradual development of intestinal fibrotic lesions containing large amounts of collagen type I, III, and V." | 1.29 | Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. ( Junker, P; Kjeldsen, J; Schaffalitzky de Muckadell, OB, 1995) |
| "ACE was decreased in Crohn's disease compared with healthy controls." | 1.28 | [Angiotensin-converting-enzyme (ACE) in Crohn's disease]. ( Fukushima, T; Sugita, A; Takeuchi, N; Tsuchiya, S, 1992) |
| "In active ulcerative colitis, A23187 and antihuman IgE induced significantly higher stimulation of PAF synthesis compared to their effects on normal mucosa." | 1.28 | Cytokines and platelet-activating factor in human inflamed colonic mucosa. ( Eliakim, R; Karmeli, F; Ligumsky, M; Rachmilewitz, D; Simon, P, 1992) |
| "Oral Crohn's disease has been reported frequently in the last two decades with and without intestinal manifestations." | 1.28 | Oral Crohn's disease with late intestinal manifestations. ( Ghandour, K; Issa, M, 1991) |
| "Sixteen patients with Crohn's disease who had symptoms uncontrolled by high-dose steroids (n = 11) or symptoms invariably appearing on reduction or withdrawal of immunosuppressive therapy (n = 5) were treated with elemental diet." | 1.28 | Elemental diet in steroid-dependent and steroid-refractory Crohn's disease. ( Cann, PA; Giaffer, MH; Holdsworth, CD; O'Brien, CJ, 1991) |
| "Cells from patients with Crohn's disease incorporated more 14C-AA into their neutral lipids than did cells from control patients." | 1.28 | Phospholipase activation and arachidonic acid release in intestinal epithelial cells from patients with Crohn's disease. ( Gustafson, C; Sjödahl, R; Tagesson, C, 1990) |
| "The Harvey-Bradshaw Crohn's disease activity index improved significantly, mainly because of reduced frequency of loose stools and diminution of abdominal pain." | 1.28 | Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation. ( Olaison, G; Sjödahl, R; Tagesson, C, 1990) |
| "Although Crohn's disease may decrease fertility, female reproductive ability is normal in UC." | 1.27 | Medical and surgical treatment of inflammatory bowel disease in pregnancy. ( Warsof, SL, 1983) |
| " Feed was infused continuously via a nasoduodenal tube in a dosage of 2600-3200 kcal/day." | 1.27 | Is tube feeding with elemental diets a primary therapy of Crohn's disease? ( Egger-Schödl, M; Lochs, H; Meryn, S; Pötzi, R; Schuh, R; Westphal, G, 1984) |
| "The pharmacokinetics and bioavailability of prednisolone after doses of oral prednisone and intravenous prednisolone were determined in seven patients receiving corticosteroids for treatment of inflammatory bowel disease in active disease and remission." | 1.27 | Effect of inflammatory bowel disease on absorption and disposition of prednisolone. ( George, DE; Jusko, WJ; Lebenthal, E; Milsap, RL; Murray, KA; Szefler, SJ, 1983) |
| "Seven patients with Crohn's disease and eight normal control subjects were given a tracer dose of tritiated prednisolone with 20 mg cold prednisolone by mouth." | 1.27 | Absorption of prednisolone in patients with Crohn's disease. ( Houston, JB; Rowland, M; Shaffer, JA; Turnberg, LA; Williams, SE, 1983) |
| "The diagnosis of Crohn's disease with extensive involvement of small intestine and colon was first made in a 12 3/4-year-old girl, now 15 1/2 years old." | 1.27 | [Crohn disease: initial experiences with cyclosporin A in an adolescent girl]. ( Dannecker, G; Malchow, H; Niessen, KH; Ranke, MB, 1985) |
| "In 6 patients with ulcerative colitis absorption was delayed until the preparation reached the colon but the total absorption was unchanged." | 1.27 | Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease. ( Dew, MJ; Evans, BK; Rhodes, J; Richards, A; Richards, D; Rogers, L; Thomas, P, 1985) |
| "Therefore, Crohn's disease of the esophagus should be considered in the differential diagnosis of biopsy-negative carcinoma of the esophagus in order to avoid major surgery." | 1.27 | Esophageal stricture in Crohn's disease--a case report. ( Iwamatsu, M; Shimizu, T; Yanaga, K; Yukizane, T, 1986) |
| "Prednisolone absorption was studied in 13 normal subjects, eight patients with ulcerative colitis and 21 patients with Crohn's disease, by measuring plasma levels after a single oral dose." | 1.27 | Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent. ( Lennard-Jones, JE; McIntyre, PB; Nabi, EM; Phongsathorn, V; Rodrigues, CA; Rosen, A; Spiliadis, C; Willoughby, JM, 1987) |
| "Twelve patients with severe Crohn's disease unresponsive to prednisone for two years were treated by twelve sessions of LCTPH over a three-week period." | 1.27 | [Treatment using lymphocytapheresis of severe forms of Crohn's disease. Preliminary results]. ( Baumann, R; Bohbot, A; Duclos, B; Faradji, A; Lang, JM; Levy, S; Oberling, F; Weill, JP, 1988) |
| "Thus, ulcerative colitis can be safely controlled by medical management unless we misjudge the timing for surgical intervention." | 1.27 | [Indications for surgery from the point of view of an internist]. ( Watanabe, H, 1985) |
| " In the fulminant form of the disease the highly dosed application of prednisolone with ease the highly dosed application of prednisolone with parenteral hypercaloric nutrition and the substitution of mineral, protein and blood losses are therapeutically in the first place." | 1.26 | [Ulcerative and granulomatous colitis]. ( Bosseckert, H, 1981) |
| "The granulomatous inflammation in Crohn's disease differs from that in sarcoidosis, in which striking elevation of angiotensin-converting enzyme is present in granulomatous tissue and frequently in serum." | 1.26 | Angiotensin-converting enzyme in Crohn's disease and ulcerative colitis. ( Fierst, SM; Friedland, J; Silverstein, E; Simon, MR; Weinstock, JV, 1981) |
| "In those patients with Crohn's disease who failed to respond to corticosteroid therapy, adequate serum levels of prednisolone were achieved." | 1.26 | Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration. ( Halliday, JW; Powell, LW; Tanner, AR, 1981) |
| "6 patients with Crohn's disease for 1-14 years have been treated with plasmapheresis for periods of up to 6 months." | 1.26 | Plasmapheresis in Crohn's disease. ( Fisher, JA; Hamblin, TJ; Holdstock, GE; Loehry, C, 1979) |
| " Monitoring prednisolone levels may be of value in identifying those children who accumulate excessively high levels on moderate dosage regimens." | 1.26 | Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. ( Green, OC; Hart, RL; Kawahara, FS; Lewy, PR; Pachman, LM; Phillips, LS; Winter, RJ, 1978) |
| " The study revealed no correlation between steroid dosage and postoperative morbidity or mortality." | 1.26 | Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids. ( Allsop, JR; Lee, EC, 1978) |
| "Curative therapy of regional enteritis does not exist." | 1.26 | [Surgical and medical treatment of Crohn's disease (author's transl)]. ( Brünner, H; Eckhardt, R; Ewe, K; Krieg, H, 1977) |
| "Crohn's ileocolitis is an etiologically unclarified inflammatory disease of the alimentary canal, which is in most cases arranged in segments, may concern all segments, but above all may take place in the inferior ileum and the adjacent segments of the colon." | 1.26 | [Diagnosis and therapy of Crohn's disease]. ( Scharf, R, 1976) |
| "Five patients with Crohn's disease for 4 months to 12 years were treated with metronidazole." | 1.25 | Metronidazole for Crohn's disease. ( Kamme, C; Ursing, B, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 88 (23.66) | 18.7374 |
| 1990's | 110 (29.57) | 18.2507 |
| 2000's | 100 (26.88) | 29.6817 |
| 2010's | 62 (16.67) | 24.3611 |
| 2020's | 12 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, Y | 1 |
| Sugaya, T | 2 |
| Tanaka, T | 3 |
| Tominaga, K | 1 |
| Yoshihara, S | 1 |
| Feleshtynskiy, Y | 1 |
| Mylianovska, A | 1 |
| Pirogovsky, V | 1 |
| Dyadyk, O | 1 |
| Gardiner, LJ | 1 |
| Carrieri, AP | 1 |
| Bingham, K | 1 |
| Macluskie, G | 1 |
| Bunton, D | 1 |
| McNeil, M | 1 |
| Pyzer-Knapp, EO | 1 |
| Saifuddin, A | 1 |
| Kent, AJ | 1 |
| Mehta, SJ | 1 |
| Hicks, LC | 1 |
| Gonzalez, HA | 1 |
| Segal, JP | 1 |
| Brookes, MJ | 1 |
| Subramanian, S | 1 |
| Bhala, N | 1 |
| Conley, TE | 1 |
| Patel, KV | 1 |
| Lamb, CA | 1 |
| Walker, GJ | 1 |
| Kennedy, NA | 1 |
| Sebastian, S | 1 |
| Suga, T | 3 |
| Hidaka, Y | 3 |
| Hori, M | 3 |
| Yamasaki, H | 3 |
| Wakasugi, D | 3 |
| Yamasaki, S | 3 |
| Yamaguchi, R | 3 |
| Ida, H | 3 |
| Nakashima, M | 3 |
| Ko, YL | 3 |
| Matsuoka, H | 4 |
| Nomaru, R | 3 |
| Imakiire, S | 3 |
| Sakisaka, H | 3 |
| Matsuoka, S | 3 |
| Kuno, N | 3 |
| Abe, K | 3 |
| Funakoshi, S | 3 |
| Ishida, Y | 3 |
| Ishibashi, H | 3 |
| Miyagi, S | 3 |
| Sakata, T | 3 |
| Hirai, F | 3 |
| El-Enany, G | 1 |
| Nagui, N | 1 |
| Nada, H | 1 |
| El Ghanam, O | 1 |
| Kadry, N | 1 |
| Abdel-Halim, MRE | 1 |
| Elbendary, A | 1 |
| Jansen, FM | 1 |
| Vavricka, SR | 2 |
| den Broeder, AA | 1 |
| de Jong, EM | 1 |
| Hoentjen, F | 1 |
| van Dop, WA | 1 |
| Nabeya, D | 1 |
| Kinjo, T | 2 |
| Yamaniha, K | 1 |
| Yamazato, S | 1 |
| Tome, R | 1 |
| Miyagi, K | 1 |
| Nakamura, H | 1 |
| Haranaga, S | 1 |
| Higa, F | 1 |
| Fujita, J | 1 |
| Jongsma, MME | 1 |
| Aardoom, MA | 1 |
| Cozijnsen, MA | 1 |
| van Pieterson, M | 1 |
| de Meij, T | 1 |
| Groeneweg, M | 1 |
| Norbruis, OF | 1 |
| Wolters, VM | 1 |
| van Wering, HM | 1 |
| Hojsak, I | 1 |
| Kolho, KL | 3 |
| Hummel, T | 1 |
| Stapelbroek, J | 1 |
| van der Feen, C | 1 |
| van Rheenen, PF | 1 |
| van Wijk, MP | 1 |
| Teklenburg-Roord, STA | 1 |
| Schreurs, MWJ | 1 |
| Rizopoulos, D | 1 |
| Doukas, M | 1 |
| Escher, JC | 2 |
| Samsom, JN | 1 |
| de Ridder, L | 1 |
| Park, S | 2 |
| Lee, T | 1 |
| Lim, W | 1 |
| Park, H | 1 |
| Yun, J | 1 |
| Kim, D | 1 |
| Choi, S | 1 |
| Oh, H | 1 |
| Song, C | 1 |
| Xu, P | 1 |
| Elizalde, M | 1 |
| Masclee, A | 1 |
| Pierik, M | 1 |
| Jonkers, D | 1 |
| Tanaka, H | 1 |
| Kamata, N | 1 |
| Yamada, A | 1 |
| Endo, K | 1 |
| Fujii, T | 1 |
| Yoshino, T | 1 |
| Yokoyama, Y | 1 |
| Bamba, S | 2 |
| Umeno, J | 1 |
| Yanai, Y | 1 |
| Ishii, M | 1 |
| Kawaguchi, T | 1 |
| Shinzaki, S | 1 |
| Toya, Y | 1 |
| Kobayashi, T | 1 |
| Nojima, M | 1 |
| Hibi, T | 3 |
| Bernardes, C | 1 |
| Russo, P | 1 |
| Carvalho, D | 1 |
| Saiote, J | 1 |
| Ramos, J | 1 |
| Saito, K | 2 |
| Iwata, Y | 1 |
| Nakajima, Y | 1 |
| Numata, S | 1 |
| Sugiura, K | 1 |
| Kojima, Y | 1 |
| Hirotsu, Y | 1 |
| Omata, W | 1 |
| Sugimori, M | 1 |
| Takaoka, S | 1 |
| Ashizawa, H | 1 |
| Nakagomi, K | 1 |
| Yoshimura, D | 1 |
| Hosoda, K | 1 |
| Suzuki, Y | 1 |
| Mochizuki, H | 1 |
| Omata, M | 1 |
| Peter, J | 1 |
| Zeitz, J | 1 |
| Stallmach, A | 5 |
| Bishnoi, A | 2 |
| Kaushik, A | 1 |
| Banerjee, N | 2 |
| Nada, R | 1 |
| Parsad, D | 2 |
| Kochhar, R | 1 |
| Saikia, UN | 1 |
| Panaccione, R | 2 |
| Steinhart, AH | 1 |
| Bressler, B | 1 |
| Khanna, R | 1 |
| Marshall, JK | 1 |
| Targownik, L | 1 |
| Afif, W | 1 |
| Bitton, A | 1 |
| Borgaonkar, M | 1 |
| Chauhan, U | 1 |
| Halloran, B | 1 |
| Jones, J | 1 |
| Kennedy, E | 1 |
| Leontiadis, GI | 1 |
| Loftus, EV | 1 |
| Meddings, J | 1 |
| Moayyedi, P | 1 |
| Murthy, S | 1 |
| Plamondon, S | 1 |
| Rosenfeld, G | 1 |
| Schwartz, D | 1 |
| Seow, CH | 1 |
| Williams, C | 1 |
| Bernstein, CN | 3 |
| Atreya, R | 1 |
| Neumann, H | 1 |
| Neurath, MF | 3 |
| Itano, S | 1 |
| Nagayama, I | 1 |
| Yamaguchi, Y | 1 |
| Mori, D | 1 |
| Imakita, N | 1 |
| Takeji, M | 1 |
| Yamauchi, A | 1 |
| Ritter, J | 1 |
| Kurzai, M | 1 |
| Mentzel, HJ | 1 |
| Guntinas-Lichius, O | 1 |
| Mizoshita, T | 2 |
| Tanida, S | 2 |
| Tsukamoto, H | 2 |
| Ozeki, K | 2 |
| Katano, T | 1 |
| Ebi, M | 1 |
| Mori, Y | 1 |
| Kataoka, H | 2 |
| Kamiya, T | 2 |
| Joh, T | 2 |
| Wong, SC | 2 |
| Catto-Smith, AG | 1 |
| Zacharin, M | 1 |
| Santos-Antunes, J | 1 |
| Abreu, C | 1 |
| Magro, F | 1 |
| Coelho, R | 1 |
| Vilas-Boas, F | 1 |
| Andrade, P | 1 |
| Lopes, S | 1 |
| Macedo, G | 1 |
| Kim, EJ | 1 |
| Kim, EY | 1 |
| Song, JE | 1 |
| Lee, HC | 1 |
| Bae, GH | 1 |
| Oh, HK | 1 |
| Lee, TS | 1 |
| Sidoroff, M | 1 |
| Yoo, YJ | 1 |
| Chung, SY | 1 |
| Gu, DH | 1 |
| Ko, GJ | 1 |
| Pyo, HJ | 1 |
| Kwon, YJ | 1 |
| Bak, YT | 1 |
| Won, NH | 1 |
| Jennings, VC | 1 |
| Williams, L | 1 |
| Henson, S | 1 |
| Massa, AF | 1 |
| Campos, MA | 1 |
| Baptista, A | 1 |
| Costa, C | 1 |
| Lima, O | 1 |
| Osório Ferreira, E | 1 |
| Grover, Z | 1 |
| Lewindon, P | 1 |
| Kiyohara, H | 1 |
| Hisamatsu, T | 1 |
| Matsuoka, K | 1 |
| Naganuma, M | 1 |
| Kameda, H | 1 |
| Seta, N | 1 |
| Takeuchi, T | 1 |
| Kanai, T | 1 |
| Gekka, M | 1 |
| Sugiyama, T | 1 |
| Nomura, M | 1 |
| Kato, Y | 1 |
| Nishihara, H | 1 |
| Asaoka, K | 1 |
| Antunes, H | 1 |
| Patraquim, C | 1 |
| Baptista, V | 1 |
| Silva Monteiro, L | 1 |
| Paragomi, P | 1 |
| Moradi, K | 1 |
| Khosravi, P | 1 |
| Ansari, R | 1 |
| Eun, CS | 1 |
| Kwak, MJ | 1 |
| Han, DS | 1 |
| Lee, AR | 1 |
| Park, DI | 2 |
| Yang, SK | 3 |
| Kim, YS | 1 |
| Kim, JF | 1 |
| Ferreira, C | 1 |
| Soares, J | 1 |
| Maia, T | 1 |
| Pardal, J | 1 |
| Nogueira, A | 1 |
| Tavares, M | 1 |
| Trindade, E | 1 |
| Amil Dias, J | 1 |
| Monteiro, S | 1 |
| Moreira, MJ | 1 |
| Ribeiro, JM | 1 |
| Cotter, J | 1 |
| Park, JJ | 1 |
| Ye, BD | 2 |
| Kim, JW | 1 |
| Yoon, H | 1 |
| Im, JP | 1 |
| Lee, KM | 2 |
| Yoon, SN | 1 |
| Lee, H | 2 |
| Efthymiou, A | 1 |
| Viazis, N | 1 |
| Mantzaris, G | 1 |
| Papadimitriou, N | 1 |
| Tzourmakliotis, D | 1 |
| Raptis, S | 1 |
| Karamanolis, DG | 1 |
| Desilva, S | 1 |
| Kaplan, G | 1 |
| Komatsuda, A | 1 |
| Kinoshita, K | 1 |
| Togashi, M | 1 |
| Maki, N | 1 |
| Masai, R | 1 |
| Niitsu, H | 1 |
| Ohtani, S | 1 |
| Sageshima, M | 1 |
| Sawada, K | 1 |
| Wakui, H | 1 |
| Teshima, C | 1 |
| Fedorak, RN | 1 |
| Serrão, VV | 1 |
| Organ, V | 1 |
| Pereira, L | 1 |
| Vale, E | 1 |
| Correia, S | 1 |
| Zamvar, V | 1 |
| Sugarman, ID | 2 |
| Tawfik, RF | 1 |
| Macmullen-Price, J | 1 |
| Puntis, JW | 2 |
| Al-Mubarak, L | 1 |
| Al-Khenaizan, S | 1 |
| Al Goufi, T | 1 |
| Holtmann, MH | 1 |
| Krummenauer, F | 2 |
| Claas, C | 1 |
| Kremeyer, K | 1 |
| Lorenz, D | 1 |
| Rainer, O | 1 |
| Vogel, I | 1 |
| Böcker, U | 1 |
| Böhm, S | 1 |
| Büning, C | 1 |
| Duchmann, R | 2 |
| Gerken, G | 1 |
| Herfarth, H | 1 |
| Lügering, N | 1 |
| Kruis, W | 1 |
| Reinshagen, M | 2 |
| Schmidt, J | 1 |
| Stein, J | 2 |
| Sturm, A | 2 |
| Galle, PR | 2 |
| Hommes, DW | 1 |
| D'Haens, G | 1 |
| Rutgeerts, P | 4 |
| Tsujikawa, T | 1 |
| Andoh, A | 1 |
| Inatomi, O | 1 |
| Nakahara, T | 1 |
| Sasaki, M | 1 |
| Saito, H | 2 |
| Fujiyama, Y | 1 |
| Angelucci, E | 1 |
| Cesarini, M | 1 |
| Vernia, P | 1 |
| Murakami, A | 1 |
| Tanaka, Y | 1 |
| Ueda, M | 1 |
| Nagano, Y | 1 |
| Kunisaki, R | 1 |
| Morimoto, M | 1 |
| Enaka, M | 1 |
| Tanabe, M | 1 |
| Kawachi, K | 1 |
| Sasaki, T | 1 |
| Nozawa, A | 1 |
| Andreani, SM | 1 |
| Ratnasingham, K | 1 |
| Dang, HH | 1 |
| Gravante, G | 1 |
| Giordano, P | 1 |
| Øresland, T | 1 |
| Moum, B | 1 |
| Raithel, M | 1 |
| Nägel, A | 1 |
| Zopf, Y | 1 |
| deRossi, T | 1 |
| Stengel, Ch | 1 |
| Hagel, A | 1 |
| Kressel, J | 1 |
| Hahn, EG | 1 |
| Konturek, P | 1 |
| Leung, VK | 1 |
| Lee, CK | 1 |
| Chau, TN | 1 |
| Cheung, WI | 1 |
| Lo, FH | 1 |
| Lai, KB | 1 |
| Lin, CK | 1 |
| Maines, LW | 1 |
| Fitzpatrick, LR | 1 |
| Green, CL | 1 |
| Zhuang, Y | 1 |
| Smith, CD | 1 |
| Heidt, J | 1 |
| van der Werf, SD | 1 |
| Ooms, EC | 1 |
| Groeneveld, JH | 1 |
| Torres, J | 1 |
| Cortot, A | 5 |
| Tremblay, L | 1 |
| Colombel, JF | 4 |
| Jouet, JP | 1 |
| Allorge, D | 1 |
| Broly, F | 1 |
| Bischoff, A | 2 |
| Lee, JS | 1 |
| Lee, JH | 2 |
| Lee, HJ | 2 |
| Kim, MJ | 1 |
| Choe, YH | 1 |
| Williams, JV | 1 |
| Revington, PJ | 1 |
| Beyazit, Y | 1 |
| Caner, S | 1 |
| Kurt, M | 1 |
| Kekilli, M | 1 |
| Aydog, G | 1 |
| Ibis, M | 1 |
| Baysoy, G | 1 |
| Daar, G | 1 |
| Demir, H | 1 |
| Elmas, SA | 1 |
| Haliloğlu, M | 1 |
| Besbas, N | 1 |
| Kumar, P | 2 |
| Galloway, PJ | 1 |
| Blair, JC | 1 |
| Didi, M | 1 |
| Dalzell, AM | 1 |
| Hassan, K | 1 |
| McGrogan, P | 2 |
| Ahmed, SF | 3 |
| Lee, HY | 1 |
| Pelivani, N | 1 |
| Beltraminelli, H | 1 |
| Hegyi, I | 1 |
| Yawalkar, N | 1 |
| Borradori, L | 1 |
| Kusunoki, R | 1 |
| Ishihara, S | 1 |
| Sato, M | 1 |
| Sumita, Y | 1 |
| Mishima, Y | 1 |
| Okada, M | 4 |
| Tada, Y | 1 |
| Oka, A | 1 |
| Fukuba, N | 1 |
| Oshima, N | 1 |
| Moriyama, I | 1 |
| Yuki, T | 1 |
| Sato, S | 1 |
| Amano, Y | 1 |
| Murakawa, Y | 1 |
| Kinoshita, Y | 1 |
| Saracino, A | 1 |
| Kelly, R | 1 |
| Liew, D | 1 |
| Chong, A | 1 |
| Kang, SJ | 1 |
| Moon, W | 1 |
| Park, MI | 1 |
| Kim, KJ | 1 |
| Kim, JB | 1 |
| Park, MJ | 1 |
| Park, SJ | 1 |
| Chang, HK | 1 |
| Shin, SJ | 1 |
| Jang, BI | 1 |
| Cheon, JH | 1 |
| Choi, CH | 1 |
| Kim, YH | 1 |
| Malik, S | 2 |
| Wilson, ML | 1 |
| Shah, N | 1 |
| Loganathan, S | 1 |
| Naik, S | 1 |
| Bourke, B | 1 |
| Thomas, A | 1 |
| Akobeng, AK | 1 |
| Fagbemi, A | 1 |
| Wilson, DC | 1 |
| Russell, RK | 2 |
| Mizushima, T | 1 |
| Hirata, Y | 1 |
| Murakami, K | 1 |
| Shimura, T | 1 |
| El-Hussuna, A | 1 |
| Andersen, J | 2 |
| Bisgaard, T | 1 |
| Jess, P | 1 |
| Henriksen, M | 1 |
| Oehlenschlager, J | 1 |
| Thorlacius-Ussing, O | 2 |
| Olaison, G | 4 |
| Mäkitalo, L | 1 |
| Rintamäki, H | 1 |
| Tervahartiala, T | 1 |
| Sorsa, T | 1 |
| Muhammad, R | 1 |
| Wong, CL | 1 |
| Limdi, JK | 1 |
| Rosmaninho, A | 1 |
| Sanches, M | 1 |
| Fernandes, IC | 1 |
| Pinto-Almeida, T | 1 |
| Vilaça, S | 1 |
| Oliveira, A | 1 |
| Selores, M | 1 |
| Uchino, M | 1 |
| Ikeuchi, H | 1 |
| Bando, T | 1 |
| Takahashi, Y | 1 |
| Takesue, Y | 1 |
| Matsumoto, T | 2 |
| Tomita, N | 1 |
| Mason, A | 1 |
| Bakhshi, A | 1 |
| Young, D | 1 |
| Bishop, J | 1 |
| Garrick, V | 1 |
| Martin, C | 1 |
| Steinke, T | 1 |
| Bucher, M | 1 |
| Raspé, C | 1 |
| Pimentel, R | 1 |
| Lago, P | 1 |
| Pedroto, I | 1 |
| Yamamoto, T | 2 |
| Shiraki, M | 1 |
| Triantafillidis, JK | 1 |
| Penesis, G | 1 |
| Manz, M | 1 |
| Wanner, R | 1 |
| Lakatos, PL | 1 |
| Rogler, G | 3 |
| Frei, P | 1 |
| Safroneeva, E | 1 |
| Schoepfer, AM | 1 |
| Herrlinger, KR | 2 |
| Diculescu, M | 1 |
| Fellermann, K | 1 |
| Hartmann, H | 1 |
| Howaldt, S | 1 |
| Nikolov, R | 1 |
| Petrov, A | 1 |
| Reindl, W | 1 |
| Otte, JM | 1 |
| Stoynov, S | 1 |
| Strauch, U | 1 |
| Voiosu, R | 1 |
| Ammendola, A | 1 |
| Dietrich, B | 1 |
| Hentsch, B | 1 |
| Stange, EF | 2 |
| Schreiber, S | 4 |
| Rosenstiel, P | 1 |
| Hampe, J | 2 |
| Nikolaus, S | 2 |
| Groessner, B | 1 |
| Schottelius, A | 2 |
| Kühbacher, T | 1 |
| Hämling, J | 2 |
| Fölsch, UR | 1 |
| Seegert, D | 1 |
| de Jong, DJ | 1 |
| Corstens, FH | 1 |
| Mannaerts, L | 1 |
| van Rossum, LG | 1 |
| Naber, AH | 1 |
| Jacob, R | 1 |
| Walsh, C | 1 |
| Hunter, JO | 2 |
| Saatci, OA | 1 |
| Koçak, N | 1 |
| Durak, I | 1 |
| Ergin, MH | 1 |
| Takemura, T | 1 |
| Yagi, K | 1 |
| Kuwajima, H | 1 |
| Yanagida, H | 1 |
| Ugarte, M | 1 |
| Wearne, IM | 1 |
| Holtmann, M | 1 |
| Wanitschke, R | 2 |
| Helisch, A | 1 |
| Bartenstein, P | 1 |
| Neurath, M | 1 |
| Schölmerich, J | 3 |
| Fleig, WE | 2 |
| Ochsenkühn, T | 1 |
| Sackmann, M | 1 |
| Göke, B | 1 |
| Nagy, F | 1 |
| Wittig, BM | 1 |
| Moser, C | 1 |
| Fischinger, J | 1 |
| Zeitz, M | 1 |
| Monk, BE | 1 |
| Skipper, D | 1 |
| Bogenrieder, T | 1 |
| Vogt, T | 1 |
| Landthaler, M | 1 |
| Stolz, W | 1 |
| Beglinger, Ch | 1 |
| Diedrich, J | 1 |
| Görg, C | 1 |
| Eissele, R | 1 |
| Arnold, R | 1 |
| Jo, Y | 1 |
| Yada, S | 1 |
| Fujisawa, K | 1 |
| Esaki, M | 1 |
| Onai, N | 1 |
| Matsushima, K | 1 |
| Iida, M | 1 |
| Christopoulos, C | 1 |
| Savva, S | 1 |
| Pylarinou, S | 1 |
| Diakakis, A | 1 |
| Papavassiliou, E | 1 |
| Economopoulos, P | 1 |
| Boruchowicz, A | 1 |
| Gallon, P | 1 |
| Foissey, D | 1 |
| Gower, P | 1 |
| Gamblin, C | 1 |
| Cuingnet, P | 1 |
| Maunoury, V | 1 |
| Izumiya, M | 1 |
| Yajima, T | 1 |
| Serizawa, H | 1 |
| Watanabe, N | 1 |
| Hamada, Y | 1 |
| Tsunematsu, S | 1 |
| Kumagai, N | 1 |
| Tsuchimoto, K | 1 |
| Toyoda, H | 1 |
| Ishii, H | 1 |
| GROTH, H | 1 |
| BORMANN, H | 1 |
| GILL, AM | 1 |
| OTAKI, AT | 1 |
| DALY, JR | 1 |
| SPENCER-PEET, J | 1 |
| von Tirpitz, C | 1 |
| Epp, S | 1 |
| Klaus, J | 1 |
| Mason, R | 1 |
| Hawa, G | 1 |
| Brinskelle-Schmal, N | 1 |
| Hofbauer, LC | 1 |
| Adler, G | 1 |
| Kratzer, W | 1 |
| Teml, A | 1 |
| Kratzer, V | 1 |
| Schneider, B | 1 |
| Lochs, H | 7 |
| Norman, GL | 1 |
| Gangl, A | 5 |
| Vogelsang, H | 8 |
| Reinisch, W | 7 |
| Giese, T | 2 |
| Schmidt, C | 2 |
| Ludwig, B | 1 |
| Mueller-Molaian, I | 1 |
| Meuer, SC | 2 |
| Yamagishi, F | 1 |
| Bruewer, M | 1 |
| Utech, M | 1 |
| Rijcken, EJ | 1 |
| Anthoni, C | 1 |
| Laukoetter, MG | 1 |
| Kersting, S | 1 |
| Senninger, N | 1 |
| Krieglstein, CF | 1 |
| Jess, T | 1 |
| Winther, KV | 1 |
| Munkholm, P | 5 |
| Langholz, E | 2 |
| Binder, V | 3 |
| Schluter, A | 1 |
| Krasnianski, M | 1 |
| Krivokuca, M | 1 |
| Spielmann, RP | 1 |
| Neudecker, S | 1 |
| Hirsch, W | 1 |
| Ng, JP | 1 |
| Soliman, A | 1 |
| Kumar, B | 1 |
| Lam, DC | 1 |
| Omori, H | 1 |
| Asahi, H | 1 |
| Inoue, Y | 1 |
| Irinoda, T | 1 |
| Lerebours, E | 2 |
| Savoye, G | 1 |
| Stiefelhagen, P | 1 |
| Kubota, Y | 2 |
| Hosogi, S | 1 |
| Iwasaki, Y | 1 |
| Weigand, K | 1 |
| Wagner-Thiessen, E | 1 |
| Stolte, M | 1 |
| Tobias, JH | 1 |
| Sasi, MR | 1 |
| Greenwood, R | 1 |
| Probert, CS | 1 |
| Domènech, E | 1 |
| Hinojosa, J | 2 |
| Esteve-Comas, M | 1 |
| Gomollón, F | 2 |
| Herrera, JM | 1 |
| Bastida, G | 1 |
| Obrador, A | 1 |
| Ruiz, R | 1 |
| Saro, C | 1 |
| Gassull, MA | 1 |
| Schoon, EJ | 1 |
| Bollani, S | 2 |
| Mills, PR | 1 |
| Israeli, E | 1 |
| Felsenberg, D | 1 |
| Ljunghall, S | 1 |
| Persson, T | 3 |
| Haptén-White, L | 1 |
| Graffner, H | 1 |
| Bianchi Porro, G | 2 |
| Vatn, M | 1 |
| Stockbrügger, RW | 1 |
| Feagan, BG | 2 |
| Sandborn, WJ | 2 |
| Baker, JP | 1 |
| Cominelli, F | 1 |
| Sutherland, LR | 1 |
| Elson, CO | 1 |
| Salzberg, BA | 1 |
| Archambault, A | 1 |
| Lichtenstein, GR | 1 |
| Heath, PK | 1 |
| Cameron, S | 1 |
| Hanauer, SB | 1 |
| Durusu, M | 1 |
| Gürlek, A | 1 |
| Simşek, H | 1 |
| Balaban, Y | 1 |
| Tatar, G | 1 |
| Newby, EA | 1 |
| Sawczenko, A | 1 |
| Thomas, AG | 3 |
| Wilson, D | 1 |
| Barthel, HR | 1 |
| Gille, T | 1 |
| Halbsguth, A | 1 |
| Kramer, M | 1 |
| Munck, LK | 1 |
| Sabat, M | 1 |
| Leulmo, J | 1 |
| Saez, A | 1 |
| Zimmermann-Nielsen, E | 1 |
| Grønbaek, H | 5 |
| Dahlerup, JF | 1 |
| Baatrup, G | 1 |
| Abreu, MT | 1 |
| Eivindson, M | 3 |
| Nielsen, JN | 4 |
| Frystyk, J | 1 |
| Flyvbjerg, A | 1 |
| Jørgensen, L | 1 |
| Vind, I | 3 |
| Jensen, S | 2 |
| Brandslund, I | 4 |
| Hey, H | 4 |
| Nielsen, AA | 2 |
| Jørgensen, LG | 1 |
| Hougaard, DM | 1 |
| Skogstrand, K | 1 |
| Schröder, O | 1 |
| Blumenstein, I | 1 |
| Agrawal, A | 1 |
| Durrani, S | 1 |
| Leiper, K | 1 |
| Ellis, A | 1 |
| Morris, AI | 1 |
| Rhodes, JM | 2 |
| Witthoeft, T | 1 |
| Raedler, A | 2 |
| Bokemeyer, B | 1 |
| Krummenerl, T | 1 |
| Schulzke, JD | 1 |
| Boerner, N | 1 |
| Kueppers, B | 1 |
| Emmrich, J | 1 |
| Mescheder, A | 1 |
| Schwertschlag, U | 1 |
| Shapiro, M | 1 |
| Preston, PW | 1 |
| Hudson, N | 1 |
| Lewis, FM | 1 |
| Poullis, A | 1 |
| Irwin, AG | 1 |
| Dearing, M | 1 |
| Gordon, C | 1 |
| Britten, AJ | 1 |
| Heenan, S | 1 |
| Maxwell, JD | 1 |
| Tan, MH | 1 |
| Chen, SD | 1 |
| Rubinstein, A | 1 |
| Bron, AJ | 1 |
| Tappeiner, C | 1 |
| Dohrmann, J | 1 |
| Spital, G | 1 |
| Heiligenhaus, A | 1 |
| Noto, H | 1 |
| Iimura, M | 1 |
| Karibe, T | 1 |
| Tanishima, M | 1 |
| Hamura, K | 1 |
| Takasaki, T | 1 |
| Mochizuki, N | 1 |
| Torii, N | 1 |
| Iizuka, BE | 1 |
| Shiratori, K | 1 |
| Oonk, MH | 1 |
| van der Ploeg, JM | 1 |
| van Lonkhuijzen, LR | 1 |
| Vestergaard, EM | 1 |
| Nexø, E | 1 |
| Hermann, E | 1 |
| Zeuzem, S | 1 |
| Kappelman, MD | 1 |
| Bousvaros, A | 1 |
| Hyams, J | 1 |
| Markowitz, J | 1 |
| Pfefferkorn, M | 1 |
| Kugathasan, S | 1 |
| Rosh, J | 1 |
| Otley, A | 1 |
| Mack, D | 1 |
| Griffiths, A | 2 |
| Evans, J | 1 |
| Grand, R | 1 |
| Langton, C | 1 |
| Kleinman, K | 1 |
| Finkelstein, JA | 1 |
| Itaba, S | 1 |
| Iwasa, T | 1 |
| Sadamoto, Y | 1 |
| Nasu, T | 1 |
| Misawa, T | 1 |
| Inoue, K | 1 |
| Shimokawa, H | 1 |
| Nakamura, K | 1 |
| Takayanagi, R | 1 |
| Selby, W | 1 |
| Pavli, P | 1 |
| Crotty, B | 1 |
| Florin, T | 1 |
| Radford-Smith, G | 1 |
| Gibson, P | 1 |
| Mitchell, B | 1 |
| Connell, W | 1 |
| Read, R | 1 |
| Merrett, M | 1 |
| Ee, H | 1 |
| Hetzel, D | 1 |
| Brechmann, T | 1 |
| Heyer, C | 1 |
| Schmiegel, W | 1 |
| Andrabi, SI | 1 |
| Ahmad, J | 1 |
| Rathore, MA | 1 |
| El-Hakeem, AA | 1 |
| Mahgoub, LE | 1 |
| Chetcuti, PA | 1 |
| Hanai, H | 1 |
| Iida, T | 1 |
| Takeuchi, K | 1 |
| Watanabe, F | 1 |
| Yamada, M | 1 |
| Kikuyama, M | 1 |
| Maruyama, Y | 1 |
| Iwaoka, Y | 1 |
| Hirayama, K | 1 |
| Nagata, S | 1 |
| Takai, K | 1 |
| Din, S | 1 |
| Dahele, A | 1 |
| Fennel, J | 1 |
| Aitken, S | 1 |
| Shand, AG | 1 |
| Arnott, ID | 1 |
| Satsangi, J | 1 |
| Dhruva, PK | 1 |
| Price, PE | 1 |
| Torkington, J | 1 |
| Bosseckert, H | 1 |
| Bartnik, W | 1 |
| Shorter, RG | 1 |
| Morettini, A | 1 |
| Scartabelli, S | 1 |
| Bechi, P | 1 |
| Bartolozzi, C | 1 |
| Taddei, GL | 1 |
| Bartoletti, L | 1 |
| D'Albasio, G | 2 |
| Allamani, A | 1 |
| Macrae, FA | 1 |
| Warsof, SL | 1 |
| Stave, R | 1 |
| Farthing, MJ | 3 |
| Dawson, AM | 3 |
| Egger-Schödl, M | 1 |
| Schuh, R | 1 |
| Meryn, S | 1 |
| Westphal, G | 1 |
| Pötzi, R | 1 |
| Verbraeken, H | 1 |
| Ryckaert, S | 1 |
| Demets, W | 1 |
| Malchow, H | 6 |
| Daiss, W | 1 |
| Silverstein, E | 1 |
| Fierst, SM | 1 |
| Simon, MR | 1 |
| Weinstock, JV | 1 |
| Friedland, J | 1 |
| Lee, FL | 1 |
| Murray, SM | 1 |
| Prior, J | 1 |
| Shreeve, DR | 1 |
| Lennard-Jones, JE | 3 |
| Saverymuttu, SH | 1 |
| Lavender, JP | 1 |
| Hodgson, HJ | 2 |
| Chadwick, VS | 2 |
| O'Moráin, C | 1 |
| Segal, AW | 1 |
| Levi, AJ | 1 |
| Buxton-Thomas, MS | 1 |
| Dickinson, RJ | 1 |
| Maltby, P | 1 |
| Wraight, EP | 1 |
| Bergrem, H | 1 |
| Opedal, I | 1 |
| Milsap, RL | 1 |
| George, DE | 1 |
| Szefler, SJ | 1 |
| Murray, KA | 1 |
| Lebenthal, E | 1 |
| Jusko, WJ | 1 |
| Shaffer, JA | 1 |
| Williams, SE | 1 |
| Turnberg, LA | 1 |
| Houston, JB | 1 |
| Rowland, M | 1 |
| Khwaja, MS | 1 |
| Thakur, PS | 1 |
| Lawrie, JH | 1 |
| Tanner, AR | 1 |
| Halliday, JW | 1 |
| Powell, LW | 1 |
| Van Ierssel, AJ | 1 |
| Van der Sluys Veer, A | 3 |
| Verspaget, HW | 3 |
| Griffioen, G | 2 |
| Van Hogezand, RA | 3 |
| Lamers, CB | 3 |
| Novacek, G | 2 |
| Kleinberger, M | 1 |
| Moser, G | 4 |
| Smedh, K | 1 |
| Teder, K | 1 |
| Sjödahl, R | 3 |
| Weber, P | 1 |
| Zimmer, KP | 1 |
| Holly, JM | 1 |
| Taylor, F | 2 |
| Miller, V | 3 |
| Kirkin, BV | 1 |
| Mikhaĭlova, TL | 2 |
| Maiat, KE | 1 |
| Papadopoulou, A | 1 |
| Rawashdeh, MO | 1 |
| Brown, GA | 1 |
| McNeish, AS | 1 |
| Booth, IW | 1 |
| van Ierssel, GJ | 2 |
| Ruuska, T | 1 |
| Savilahti, E | 1 |
| Mäki, M | 1 |
| Ormälä, T | 1 |
| Visakorpi, JK | 1 |
| Lisby, G | 1 |
| Engbaek, K | 1 |
| Malka, D | 1 |
| Lévy, P | 1 |
| Chemtob, A | 1 |
| Bernades, P | 1 |
| Gasché, C | 3 |
| Wyatt, J | 2 |
| Dwarakanath, AD | 1 |
| Nash, J | 1 |
| Kayaba, Y | 1 |
| Hiwatashi, N | 2 |
| Nagatomi, R | 1 |
| Toyota, T | 1 |
| Majima, T | 1 |
| Beattie, RM | 2 |
| Walker-Smith, JA | 5 |
| Nicholls, S | 1 |
| Domizio, P | 2 |
| Williams, CB | 2 |
| Dawnay, A | 1 |
| Braegger, CP | 2 |
| MacDonald, TT | 3 |
| Bussel, A | 1 |
| Modigliani, R | 3 |
| Bastit, D | 1 |
| Florent, C | 2 |
| Rabian, C | 1 |
| René, E | 4 |
| Soulé, JC | 4 |
| Löfberg, R | 1 |
| Lamers, C | 1 |
| Jewell, D | 1 |
| Danielsson, A | 1 |
| Goebell, H | 1 |
| Thomsen, OO | 1 |
| Lorenz-Meyer, H | 3 |
| Sachar, DB | 1 |
| Torresani, T | 1 |
| Murch, SH | 1 |
| Savage, MO | 1 |
| Peltz, S | 1 |
| Vestey, JP | 1 |
| Ferguson, A | 2 |
| Hunter, JA | 1 |
| McLaren, K | 1 |
| Stevens, TR | 1 |
| Smith, SF | 1 |
| Rampton, DS | 1 |
| Hirakawa, H | 1 |
| Fukuda, Y | 1 |
| Tanida, N | 1 |
| Hosomi, M | 1 |
| Shimoyama, T | 1 |
| Omata, F | 1 |
| Arakawa, S | 1 |
| Takahashi, H | 1 |
| Ueno, F | 1 |
| Davidsen, M | 1 |
| Swift, GL | 1 |
| Srivastava, ED | 1 |
| Stone, R | 1 |
| Pullan, RD | 1 |
| Newcombe, RG | 1 |
| Rhodes, J | 3 |
| Wilkinson, S | 1 |
| Rhodes, P | 1 |
| Roberts, G | 1 |
| Lawrie, BW | 1 |
| Newton, M | 1 |
| Cooper, BT | 2 |
| Tan, WC | 1 |
| Allan, RN | 1 |
| González-Huix, F | 1 |
| de León, R | 1 |
| Fernández-Bañares, F | 1 |
| Esteve, M | 1 |
| Cabré, E | 1 |
| Acero, D | 1 |
| Abad-Lacruz, A | 1 |
| Figa, M | 1 |
| Guilera, M | 1 |
| Planas, R | 1 |
| Ewe, K | 2 |
| Press, AG | 1 |
| Singe, CC | 1 |
| Stufler, M | 1 |
| Ueberschaer, B | 1 |
| Hommel, G | 1 |
| Meyer zum Büschenfelde, KH | 2 |
| Griffiths, AM | 2 |
| Nguyen, P | 1 |
| Smith, C | 1 |
| MacMillan, JH | 1 |
| Sherman, PM | 1 |
| Wirth, HP | 1 |
| Zala, G | 1 |
| Meyenberger, C | 1 |
| Jost, R | 1 |
| Ammann, R | 1 |
| Münch, R | 1 |
| Gorard, DA | 1 |
| Hunt, JB | 1 |
| Payne-James, JJ | 1 |
| Palmer, KR | 1 |
| Rees, RG | 1 |
| Clark, ML | 1 |
| Misiewicz, JJ | 1 |
| Silk, DB | 1 |
| Roediger, WE | 1 |
| Giles, A | 1 |
| Kaczmar, A | 1 |
| Ali, S | 1 |
| Finkel, Y | 1 |
| Bergdahl, S | 1 |
| Molander, ML | 1 |
| Nyberg, G | 1 |
| Pal, A | 1 |
| Svennilson, J | 1 |
| Björnestam, B | 1 |
| Nyquist, K | 1 |
| Díaz Blasco, J | 1 |
| Robledo Andrés, P | 1 |
| Kjeldsen, J | 2 |
| Schaffalitzky de Muckadell, OB | 2 |
| Junker, P | 1 |
| Candy, S | 1 |
| Wright, J | 1 |
| Gerber, M | 1 |
| Adams, G | 1 |
| Gerig, M | 1 |
| Goodman, R | 1 |
| Ly, S | 1 |
| Beylot-Barry, M | 1 |
| Beyssac, R | 1 |
| Doutre, MS | 1 |
| Beylot, C | 1 |
| Breese, EJ | 1 |
| Michie, CA | 1 |
| Nicholls, SW | 1 |
| Odeka, EB | 1 |
| Dupas, JL | 1 |
| Dapoigny, M | 1 |
| Costil, V | 1 |
| Veyrac, M | 1 |
| Duclos, B | 2 |
| Gendre, JP | 3 |
| Galmiche, JP | 1 |
| Danne, O | 1 |
| Cadiot, G | 1 |
| Lamouliatte, H | 1 |
| Belaïche, J | 1 |
| Mary, JY | 2 |
| Baert, F | 1 |
| Asakura, H | 1 |
| Kapiotis, S | 1 |
| Gmeiner, B | 1 |
| Messori, A | 1 |
| Trallori, G | 1 |
| Milla, M | 1 |
| Vannozzi, G | 1 |
| Pacini, F | 1 |
| Bauer, P | 1 |
| Nicolay, C | 1 |
| Schulz, B | 1 |
| Purrmann, J | 1 |
| Scheurlen, C | 1 |
| Koop, I | 1 |
| Pudel, V | 1 |
| Carr, L | 1 |
| Mieremet-Ooms, MA | 1 |
| van der Zon, AM | 1 |
| Wagtmans, MJ | 1 |
| Kanda, A | 1 |
| Arakawa, M | 1 |
| Sasaki, Y | 1 |
| Pereira, SP | 1 |
| Cassell, TB | 1 |
| Engelman, JL | 1 |
| Sladen, GE | 1 |
| Murphy, GM | 1 |
| Dowling, RH | 1 |
| Cosgrove, M | 1 |
| Jenkins, HR | 1 |
| Bjarnason, I | 1 |
| Macpherson, A | 1 |
| Mackintosh, C | 1 |
| Buxton-Thomas, M | 1 |
| Forgacs, I | 1 |
| Moniz, C | 1 |
| Staun, M | 1 |
| Tjellesen, L | 1 |
| Thale, M | 1 |
| Schaadt, O | 1 |
| Jarnum, S | 1 |
| Gerolami, R | 1 |
| Mambrini, P | 1 |
| Barthet, M | 1 |
| Jean-Pastor, MJ | 1 |
| Salducci, J | 1 |
| Grimaud, JC | 1 |
| Thomson, AB | 1 |
| Sadowski, D | 1 |
| Jenkins, R | 1 |
| Wild, G | 1 |
| Bauditz, J | 1 |
| Haemling, J | 1 |
| Ortner, M | 1 |
| Hinterleitner, TA | 1 |
| Petritsch, W | 1 |
| Aichbichler, B | 1 |
| Fickert, P | 1 |
| Ranner, G | 1 |
| Krejs, GJ | 1 |
| Azcue, M | 1 |
| Rashid, M | 1 |
| Pencharz, PB | 1 |
| Campieri, M | 2 |
| Doe, W | 1 |
| Nilsson, LG | 1 |
| Zoli, G | 1 |
| Carè, M | 1 |
| Parazza, M | 1 |
| Spanò, C | 1 |
| Biagi, PL | 1 |
| Bernardi, M | 1 |
| Gasbarrini, G | 2 |
| Yonezawa, M | 1 |
| Tsukioka, M | 1 |
| Ogino, H | 1 |
| Satomura, Y | 1 |
| Nakagawa, H | 1 |
| Unoura, M | 1 |
| Miwa, A | 1 |
| Sargent, M | 1 |
| Rawsthorne, P | 1 |
| Rector, E | 1 |
| Malchow, HA | 1 |
| Kimura, Y | 1 |
| Yamadori, N | 1 |
| Hashimoto, N | 1 |
| Aoki, E | 1 |
| Muratani, K | 1 |
| Zenda, S | 1 |
| Dutheil, P | 1 |
| Wallach, D | 1 |
| Leibowitch, M | 1 |
| Raynaud, F | 1 |
| Dupont, C | 1 |
| Boot, AM | 1 |
| Bouquet, J | 1 |
| Krenning, EP | 1 |
| de Muinck Keizer-Schrama, SM | 1 |
| Lassen, JF | 1 |
| Eaton, TE | 1 |
| Lambie, N | 1 |
| Wells, AU | 1 |
| Shetty, AK | 1 |
| Udall, J | 1 |
| Schmidt-Sommerfeld, E | 1 |
| Minic, P | 1 |
| Perisic, VN | 1 |
| Minic, A | 1 |
| Van Deventer, SJ | 1 |
| Bartelsman, JF | 1 |
| Tytgat, GN | 2 |
| Walker, JC | 1 |
| Selva, D | 1 |
| Pietris, G | 1 |
| Crompton, JL | 1 |
| Waltz, KM | 1 |
| Long, D | 1 |
| Marks, JG | 1 |
| Billingsley, EM | 1 |
| Peters, M | 1 |
| Schlaak, JF | 1 |
| Lowry, PW | 1 |
| Mingrone, G | 1 |
| DeGaetano, A | 1 |
| Pugeat, M | 1 |
| Capristo, E | 1 |
| Greco, AV | 1 |
| Tillinger, W | 1 |
| Lichtenberger, C | 1 |
| Willheim, M | 1 |
| Dejaco, C | 1 |
| Waldhör, T | 2 |
| Bakos, S | 1 |
| Mori, M | 1 |
| Akifuji, Y | 1 |
| Ueki, J | 1 |
| Nakamoto, S | 1 |
| Uwai, M | 1 |
| Terui, Y | 1 |
| Tomizuka, H | 1 |
| Hatake, K | 1 |
| Ozawa, K | 1 |
| Miura, Y | 1 |
| Takeshima, F | 1 |
| Makiyama, K | 1 |
| Doi, T | 1 |
| Nos, P | 1 |
| Ardizzone, S | 1 |
| Bettica, P | 1 |
| Bevilacqua, M | 1 |
| Molteni, P | 1 |
| Ohta, M | 1 |
| Konno, H | 1 |
| Kamiya, K | 1 |
| Suwa, D | 1 |
| Baba, M | 1 |
| Nakamura, T | 1 |
| Nishino, N | 1 |
| Sugimura, H | 1 |
| Nakamura, S | 1 |
| Wedel, S | 1 |
| Weltrich, R | 1 |
| Rohde, W | 1 |
| Buttgereit, F | 1 |
| Rachmilewitz, D | 2 |
| Salmon, JF | 1 |
| Ursell, PG | 1 |
| Frith, P | 1 |
| Lauritsen, K | 2 |
| Winter, T | 1 |
| Pettersson, E | 1 |
| Carter, MJ | 1 |
| Lobo, AJ | 2 |
| Nakano, M | 1 |
| Miehsler, W | 1 |
| Verma, S | 1 |
| Holdsworth, CD | 2 |
| Giaffer, MH | 2 |
| Haugeberg, G | 1 |
| Vetvik, K | 1 |
| Stallemo, A | 1 |
| Bitter, H | 1 |
| Mikkelsen, B | 1 |
| Stokkeland, M | 1 |
| Lankarani, KB | 1 |
| Nahavandi, H | 1 |
| Santella, R | 1 |
| Zhang, Y | 1 |
| Knobler, R | 1 |
| Henry, MT | 1 |
| Davidson, LA | 1 |
| Cooke, NJ | 1 |
| Yao, T | 4 |
| Gelbmann, CM | 1 |
| Gross, V | 1 |
| Gierend, M | 1 |
| Bregenzer, N | 1 |
| Andus, T | 1 |
| Bergman, L | 2 |
| Krause, U | 2 |
| Cavell, B | 1 |
| Hildebrand, H | 1 |
| Meeuwisse, GW | 1 |
| Lindquist, B | 1 |
| Fuchigami, T | 1 |
| Fedorov, VD | 1 |
| Levitan, MKh | 1 |
| Oleĭnikov, PN | 1 |
| Kolosov, IA | 1 |
| Gaia, E | 1 |
| Morello, C | 1 |
| Roatta, L | 1 |
| Cavallero, M | 1 |
| Bonard, R | 1 |
| Banche, M | 1 |
| Ursing, B | 1 |
| Kamme, C | 1 |
| Holdstock, GE | 1 |
| Fisher, JA | 1 |
| Hamblin, TJ | 1 |
| Loehry, C | 1 |
| Atherton, DJ | 1 |
| Massam, M | 1 |
| Wells, RS | 1 |
| Harries, JT | 1 |
| Pincott, JR | 1 |
| Green, OC | 1 |
| Winter, RJ | 1 |
| Kawahara, FS | 1 |
| Phillips, LS | 1 |
| Lewy, PR | 1 |
| Hart, RL | 1 |
| Pachman, LM | 1 |
| Allsop, JR | 1 |
| Lee, EC | 1 |
| Krieg, H | 1 |
| Brünner, H | 1 |
| Eckhardt, R | 1 |
| Scharf, R | 1 |
| Wallis, SM | 1 |
| Walker-Smith, J | 1 |
| Kasper, H | 2 |
| Auer, I | 1 |
| Lee, E | 1 |
| Tripathi, RC | 1 |
| Kipp, MA | 1 |
| Tripathi, BJ | 1 |
| Kirschner, BS | 1 |
| Borisuth, NS | 1 |
| Shevell, SK | 1 |
| Ernest, JT | 1 |
| Takeuchi, N | 2 |
| Fukushima, T | 1 |
| Sugita, A | 2 |
| Tsuchiya, S | 2 |
| Eliakim, R | 1 |
| Simon, P | 1 |
| Ligumsky, M | 1 |
| Karmeli, F | 1 |
| Sasagawa, T | 1 |
| Sobhani, I | 1 |
| Hochlaf, S | 1 |
| Denizot, Y | 1 |
| Vissuzaine, C | 1 |
| Benveniste, J | 1 |
| Lewin, MM | 1 |
| Mignon, M | 1 |
| Goudet, P | 1 |
| Pillon, D | 1 |
| Bensa, F | 1 |
| Collet, E | 1 |
| Cougard, P | 1 |
| Viard, H | 1 |
| Landi, B | 1 |
| Anh, TN | 1 |
| Bories, P | 1 |
| See, A | 1 |
| Metman, EH | 1 |
| Masamune, O | 1 |
| Kopeĭkin, VN | 1 |
| Bogdanovich, NE | 1 |
| Lukoianova, GM | 1 |
| Kopylov, MV | 1 |
| Sheliakhina, NE | 1 |
| Ecker, KW | 1 |
| Güremen, A | 1 |
| Feifel, G | 1 |
| Schneider, W | 1 |
| Hänert, E | 1 |
| Ghandour, K | 1 |
| Issa, M | 1 |
| Sawada, T | 1 |
| Muto, T | 1 |
| Brynskov, J | 2 |
| Freund, L | 1 |
| Nørby Rasmussen, S | 1 |
| Schaffalitzky de Muckadell, O | 1 |
| Williams, CN | 1 |
| MacDonald, AS | 1 |
| Tanton, R | 1 |
| Molina, F | 1 |
| Campanini, MC | 1 |
| O'Brien, CJ | 1 |
| Cann, PA | 1 |
| Juby, LD | 1 |
| Rothwell, J | 1 |
| Poole, TW | 1 |
| Axon, AT | 1 |
| Goode, HF | 1 |
| Rathbone, BJ | 1 |
| Kelleher, J | 1 |
| Walker, BE | 1 |
| Simon, JF | 1 |
| Takenaka, K | 1 |
| Imamura, K | 1 |
| Maeda, K | 1 |
| Fujita, K | 1 |
| Mahida, YR | 1 |
| Gallagher, A | 1 |
| Kurlak, L | 1 |
| Hawkey, CJ | 1 |
| Gustafson, C | 1 |
| Tagesson, C | 2 |
| Mallett, P | 1 |
| Murch, S | 1 |
| Milov, DE | 1 |
| Hill, M | 1 |
| Andres, JM | 1 |
| Cynamon, HA | 1 |
| Hendeles, L | 1 |
| Fukusima, T | 1 |
| Imai, S | 1 |
| Yamazaki, Y | 1 |
| Dannecker, G | 1 |
| Niessen, KH | 1 |
| Ranke, MB | 1 |
| Strohm, WD | 1 |
| Classen, M | 1 |
| Miller, B | 1 |
| Stock, H | 1 |
| Brandes, JW | 2 |
| Hall, MJ | 1 |
| Thomas, WE | 1 |
| Thomas, P | 1 |
| Richards, D | 1 |
| Richards, A | 1 |
| Rogers, L | 1 |
| Evans, BK | 1 |
| Dew, MJ | 1 |
| Rabast, U | 1 |
| Heskamp, R | 1 |
| Sanderson, IR | 1 |
| Yanaga, K | 1 |
| Iwamatsu, M | 1 |
| Yukizane, T | 1 |
| Shimizu, T | 1 |
| Mohácsi, G | 1 |
| Benkó, G | 1 |
| Mágori, A | 1 |
| György, A | 1 |
| Sonkodi, S | 1 |
| Schmitz-Moormann, P | 1 |
| Jesdinsky, H | 1 |
| Knapp, M | 1 |
| Labeille, B | 1 |
| Gineston, JL | 1 |
| Denoeux, JP | 1 |
| Capron, JP | 1 |
| Inoue, M | 1 |
| Rodrigues, CA | 1 |
| Nabi, EM | 1 |
| Spiliadis, C | 1 |
| McIntyre, PB | 1 |
| Phongsathorn, V | 1 |
| Rosen, A | 1 |
| Willoughby, JM | 3 |
| Rose, J | 1 |
| Faradji, A | 1 |
| Bohbot, A | 1 |
| Baumann, R | 1 |
| Levy, S | 1 |
| Lang, JM | 1 |
| Weill, JP | 1 |
| Oberling, F | 1 |
| Hinks, LJ | 1 |
| Inwards, KD | 1 |
| Lloyd, B | 1 |
| Clayton, B | 1 |
| Wales, JK | 1 |
| Milner, RD | 1 |
| Shepherd, HA | 1 |
| Barr, GD | 1 |
| Jewell, DP | 1 |
| Marbet, UA | 1 |
| Gyr, K | 1 |
| Stalder, GA | 1 |
| Saverymuttu, S | 1 |
| Nyman, M | 1 |
| Hansson, I | 1 |
| Eriksson, S | 1 |
| Watanabe, H | 1 |
| Beckett, J | 2 |
| Kumar, PJ | 1 |
| Gray, GM | 1 |
| Phlippen, R | 1 |
| Tumen, HJ | 1 |
| Hammer, B | 1 |
| Engelhart, G | 1 |
| Hügel, H | 1 |
| Gloor, F | 1 |
| Paulley, JW | 1 |
| Hart, FD | 1 |
| Johansson, SG | 1 |
| Jones, JH | 1 |
| Crean, GP | 1 |
| Loraine, JA | 1 |
| Bell, ET | 1 |
| Card, WI | 1 |
| Sircus, W | 1 |
| Mallinson, CN | 1 |
| Candy, JC | 1 |
| Cowan, R | 1 |
| Prior, A | 1 |
| Ehrenpreis, T | 1 |
| Gierup, J | 1 |
| Lagercrantz, R | 1 |
| Zimmermann, HD | 1 |
| Nägele, E | 1 |
| Ellis, JP | 1 |
| Clarke, JR | 1 |
| Richens, ER | 1 |
| Williams, MJ | 1 |
| Gough, KR | 1 |
| Ancill, RJ | 1 |
| Skinner, MD | 1 |
| Schwartz, RS | 1 |
| Brostoff, J | 1 |
| Walker, JG | 1 |
| Stepanas, AV | 1 |
| Grant, AK | 1 |
| Alp, MH | 1 |
| Jones, FA | 1 |
| Brom, B | 1 |
| Bank, S | 1 |
| Marks, IN | 1 |
| Cobb, JJ | 1 |
| Bihari, M | 1 |
| Grossman, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Top-down Infliximab Study in Kids With Crohn's Disease[NCT02517684] | Phase 4 | 100 participants (Anticipated) | Interventional | 2015-04-30 | Active, not recruiting | ||
| Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium: A Prospective Randomized Multicenter Trial[NCT02470663] | 0 participants (Actual) | Interventional | 2015-07-31 | Withdrawn (stopped due to company and Sheba did not reach an agreement) | |||
| Evaluation of Renal Involvement in Inflammatory Bowel Disease Patients[NCT04921709] | 60 participants (Anticipated) | Observational | 2021-06-01 | Recruiting | |||
| Efficacy of Infliximab Treatment Based on TDM (Therapeutic Drug Monitoring) in Adult Patients With Active Perianal Fistulizing Crohn's Disease[NCT06051253] | Phase 4 | 86 participants (Anticipated) | Interventional | 2023-10-02 | Not yet recruiting | ||
| Exploratory, Open-label Study to Demonstrate Efficacy, Safety and Tolerability of SC12267 (35 mg) in Patients With Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)[NCT00820365] | Phase 2 | 34 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Value of Contrast-enhanced Ultrasonography and Magnetic Resonance Enterography to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease Complicated by Symptomatic Small Bowel Stricture[NCT01183403] | 80 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| An Investigator Initiated Study of Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast[NCT03442088] | Phase 2 | 28 participants (Actual) | Interventional | 2018-06-01 | Completed | ||
| Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy[NCT02852694] | Phase 4 | 312 participants (Anticipated) | Interventional | 2017-02-28 | Recruiting | ||
| Open-label Withdrawal Trial of Budesonide in Patients With Immune Mediated Enteropathies[NCT03866538] | Phase 4 | 1 participants (Actual) | Interventional | 2019-09-10 | Terminated (stopped due to Study recruitment was difficult and not acheived) | ||
| Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease[NCT00152620] | 40 participants | Interventional | 2004-06-30 | Terminated (stopped due to study completed) | |||
| Treatment of Fistulous Crohn's Disease by Implant of Autologous Mesenchymal Stem Cells Derived From Adipose Tissue[NCT01157650] | Phase 1/Phase 2 | 15 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| Zinc and Inflammation in Sepsis[NCT01328509] | 39 participants (Actual) | Observational | 2012-01-31 | Completed | |||
| A Pilot Study to Evaluate the Applicability of the Crohn's Disease Endoscopy Index of Severity to Data Obtained by the Colonic Capsule Endoscopy in Ileocolonic Crohn's Disease[NCT01183845] | Phase 4 | 24 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
To assess change in IL-17 in the identified patient AM-endotype computing relative percent reduction for each subject being treated and serum marker. The median and other summary statistics of these percent change values will be computed (NCT03442088)
Timeframe: Baseline, Week 16
| Intervention | Pg/mL (Mean) | |
|---|---|---|
| Baseline | Week 16 | |
| Apremilast for Treatment of Psoriasis With the AM-endotype | 1.513 | -0.8315 |
To assess change in serum myeloperoxidase in the identified patient AM-endotype computing relative percent reduction for each subject being treated and serum marker. The median and other summary statistics of these percent change values will be computed (NCT03442088)
Timeframe: Baseline, Week 16
| Intervention | Pg/mL (Mean) | |
|---|---|---|
| Baseline | Week 16 | |
| Apremilast for Treatment of Psoriasis With the AM-endotype | 24198 | 24294 |
To assess change in Tissue Factor in the identified patient AM-endotype computing relative percent reduction for each subject being treated and serum marker. The median and other summary statistics of these percent change values will be computed (NCT03442088)
Timeframe: Baseline, Week 16
| Intervention | Pg/mL (Mean) | |
|---|---|---|
| Baseline | Week 16 | |
| Apremilast for Treatment of Psoriasis With the AM-endotype | 72.28 | 75.52 |
To assess change in in the identified patient AM-endotype computing relative percent reduction for each subject being treated and serum marker. The median and other summary statistics of these percent change values will be computed (NCT03442088)
Timeframe: Baseline, Week 16
| Intervention | Pg/mL (Mean) | |
|---|---|---|
| Baseline | Week 16 | |
| Apremilast for Treatment of Psoriasis With the AM-endotype | 14.95 | 14.26 |
For each subject, we will identify a target biomarker of abnormally elevated monocytes, among 1.) intermediate, or 2.) doublets, or 3.) platelet doubles. Each subject will thus have one identified monocyte biomarker for which relative percent change will be its basis for analysis in the primary outcome measure. We will specifically assess change from baseline to 16 weeks by computing relative percent reduction for each subject being treated. Note for example that a change of 1.5% to 1.2% is (1 - (1.2/1.5))*100% = 20% reduction. The median and other summary statistics of these percent change values will be computed. Wilcoxon's signed rank test will be used to evaluate the null hypothesis of the median percent change being 0. (NCT03442088)
Timeframe: Baseline, Week 16
| Intervention | Percent change (Mean) | |
|---|---|---|
| Baseline | Week 16 | |
| Apremilast for Treatment of Psoriasis With the AM-endotype | 0.5665 | 0.1715 |
44 reviews available for prednisolone and Colitis, Granulomatous
| Article | Year |
|---|---|
Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes.
Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; | 2020 |
Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review.
Topics: Adult; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immune Reconstitution Inflam | 2020 |
[Rational treatment of Crohn's disease].
Topics: Administration, Oral; Administration, Topical; Algorithms; Anti-Inflammatory Agents; Budesonide; Cec | 2013 |
Pathological fractures in paediatric patients with inflammatory bowel disease.
Topics: Adolescent; Body Height; Body Weight; Bone Density; Child; Colitis, Ulcerative; Crohn Disease; Dipho | 2014 |
Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review.
Topics: Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Herpes Simp | 2014 |
Severe Lower Gastrointestinal Bleeding in a Patient with Crohn's Disease: a Case Report and the Review of Literature.
Topics: Adrenal Cortex Hormones; Adult; Crohn Disease; Female; Gastrointestinal Hemorrhage; Humans; Predniso | 2015 |
[Second Korean Guidelines for the Management of Crohn's Disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans; Infliximab; Mercaptopuri | 2017 |
Sequential therapies for Crohn's disease: optimizing conventional and biologic strategies.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aza | 2008 |
Crohn's disease of the vulva.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Combined Modality Therapy; Crohn Disease; Female; H | 2010 |
Amicrobial pustulosis-like rash in a patient with Crohn's disease under anti-TNF-alpha blocker.
Topics: Acute Generalized Exanthematous Pustulosis; Amoxicillin-Potassium Clavulanate Combination; Antibodie | 2011 |
Rare case of Takayasu's arteritis associated with Crohn's disease.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Aspirin; Coronary Artery Bypass; Crohn Disease; Cyclo | 2011 |
Therapy of steroid-resistant inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Diseas | 2012 |
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Bude | 2003 |
[Conservative therapy of inflammatory bowel diseases].
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chro | 2002 |
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Diagnosis, Differential; Granulo | 2003 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; An | 2003 |
Localised gastrocnemius myositis in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Crohn Disease; Female; Huma | 2003 |
[A case of Crohn's disease complicated with hepatocellular carcinoma].
Topics: Adult; Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Crohn Disease; Drug Combinations; Drug T | 2003 |
[Measures for tuberculosis in compromised hosts--mainly on chemoprophylaxis].
Topics: Antibiotic Prophylaxis; Antitubercular Agents; Arthritis, Rheumatoid; Collagen Diseases; Crohn Disea | 2003 |
Auto-immune haemolytic anaemia and Crohn's disease: a case report and review of the literature.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Crohn Disease; Humans; Male; Prednis | 2004 |
Pulmonary involvement in Crohn's disease report of a case and review of the literature.
Topics: Adult; Angiography; Biopsy, Needle; Combined Modality Therapy; Crohn Disease; Drug Therapy, Combinat | 2004 |
Interventions for growth failure in childhood Crohn's disease.
Topics: Adrenal Cortex Hormones; Antimetabolites; Child; Crohn Disease; Enteral Nutrition; Growth Disorders; | 2005 |
[Treatment of inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Biological Products; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamin | 2007 |
Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.
Topics: Adrenal Cortex Hormones; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Human | 1983 |
[Advances in the topical steroid treatment of inflammatory bowel diseases].
Topics: Administration, Topical; Androstadienes; Anti-Inflammatory Agents; Beclomethasone; Budesonide; Clini | 1995 |
[Sweet syndrome associated with Crohn disease].
Topics: Crohn Disease; Female; Glucocorticoids; Humans; Middle Aged; Prednisolone; Sweet Syndrome | 1995 |
[Ulcerative colitis and Crohn disease].
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Immunoglobulin G; Immunosuppre | 1996 |
Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis.
Topics: Adult; Crohn Disease; Food, Formulated; Glucocorticoids; Humans; Prednisolone; Prednisone; Randomize | 1996 |
Budesonide in the management of patients with Crohn's disease.
Topics: Anti-Inflammatory Agents; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Administ | 1997 |
[A case of Crohn's disease associated with pyoderma gangrenosum].
Topics: Adult; Colitis; Crohn Disease; Humans; Male; Parenteral Nutrition, Total; Prednisolone; Pyoderma Gan | 1997 |
Optic disc swelling in Crohn's disease.
Topics: Adult; Biopsy; Colonoscopy; Crohn Disease; Diagnosis, Differential; Drug Administration Routes; Fema | 1998 |
Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Glucocorticoids; Humans; Mesalamine; Meta-An | 1998 |
[Budesonide and inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; | 1999 |
[Medical treatment of Crohn's disease].
Topics: Antibodies, Monoclonal; Azathioprine; CD4 Antigens; Crohn Disease; Enteral Nutrition; Heparin; Human | 2000 |
[New therapeutic modalities in Crohn's disease].
Topics: Anti-Inflammatory Agents; Budesonide; Crohn Disease; Humans; Mesalamine; Prednisolone | 1999 |
[Crohn's disease].
Topics: Antibodies; Crohn Disease; Diagnosis, Differential; Humans; Macrophages; Nutritional Support; Predni | 2000 |
New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Topics: Acute Disease; Aspirin; Beclomethasone; Budesonide; Colitis, Ulcerative; Crohn Disease; Drug Therapy | 2002 |
[Progress in diagnosis and treatment of Crohn disease].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Biomarkers; Biopsy; Budesonide; Car | 2002 |
[Corticosteroids in gastroenterology].
Topics: Adrenal Cortex Hormones; Burns, Chemical; Celiac Disease; Chronic Disease; Colitis, Ulcerative; Croh | 1978 |
[Parenteral and enteral nutrition for conservative treatment of inflammatory bowel disease].
Topics: Behcet Syndrome; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Humans; Parenteral Nutrition | 1991 |
The role of ciclosporin therapy in Crohn's disease. A review.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Enema; Humans; Predniso | 1991 |
Chronic inflammatory bowel disease.
Topics: Child; Colectomy; Colitis, Ulcerative; Crohn Disease; Enema; Food, Formulated; Humans; Prednisolone; | 1986 |
Does food affect acute inflammatory bowel disease? The role of parenteral nutrition, elemental and exclusion diets.
Topics: Acute Disease; Colitis, Ulcerative; Crohn Disease; Food, Formulated; Humans; Parenteral Nutrition; P | 1986 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
65 trials available for prednisolone and Colitis, Granulomatous
| Article | Year |
|---|---|
Evaluation of the endoscopic treatment with topical prednisolone administration for intestinal strictures in Crohn's disease.
Topics: Colonoscopy; Constriction, Pathologic; Crohn Disease; Dilatation; Humans; Intestinal Obstruction; Pr | 2021 |
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; | 2022 |
Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease.
Topics: Absorptiometry, Photon; Adult; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conserv | 2009 |
Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Diseas | 2010 |
A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohn's disease.
Topics: Adolescent; Body Height; Child; Crohn Disease; Enteral Nutrition; Female; Glucose; Homeostasis; Huma | 2011 |
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biphenyl Compounds; Blood Sedimentation; C-Reac | 2013 |
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Topics: Adolescent; Adult; Antibodies, Fungal; Biomarkers; Child; Crohn Disease; Enzyme-Linked Immunosorbent | 2003 |
Budesonide versus prednisolone for the treatment of active Crohn's disease in children: a randomized, double-blind, controlled, multicentre trial.
Topics: Adolescent; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Budesonide; Child; Crohn Disease; | 2004 |
Rapid hip bone loss in active Crohn's disease patients receiving short-term corticosteroid therapy.
Topics: Adult; Age of Onset; Bone Demineralization, Pathologic; Bone Density; Crohn Disease; Female; Femur N | 2004 |
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Bone Density; Budesonide; Crohn Disease; Do | 2005 |
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Bu | 2005 |
Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Topics: Anti-Inflammatory Agents; Bone Density; Budesonide; Crohn Disease; Delayed-Action Preparations; Doub | 2005 |
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Biomarkers; Body Mass Index; C-Reactive Protein; C | 2005 |
Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids.
Topics: Administration, Oral; Adult; Body Mass Index; Crohn Disease; Cytokines; Fatty Acids, Omega-3; Fatty | 2005 |
Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study.
Topics: Adult; Antibodies, Monoclonal; Chronic Disease; Crohn Disease; Drug Administration Schedule; Drug Th | 2006 |
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Topics: Administration, Oral; Anti-Inflammatory Agents; Crohn Disease; Double-Blind Method; Female; Glucocor | 2006 |
Impact of enteral supplements enriched with omega-3 fatty acids and/or omega-6 fatty acids, arginine and ribonucleic acid compounds on leptin levels and nutritional status in active Crohn's disease treated with prednisolone.
Topics: Adolescent; Adult; Aged; Arginine; Body Mass Index; Crohn Disease; Dietary Supplements; Double-Blind | 2007 |
Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Double-Blind Method; Drug | 2007 |
Assessment of disease activity in inflammatory bowel disease: a new approach using 111In granulocyte scanning.
Topics: Colitis, Ulcerative; Crohn Disease; Female; Granulocytes; Humans; Indium; Male; Prednisolone; Radioi | 1983 |
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.
Topics: Acute Disease; Adult; Amino Acids; Clinical Trials as Topic; Crohn Disease; Dietary Proteins; Female | 1984 |
Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease.
Topics: Adult; Budesonide; Cell Count; Crohn Disease; Cytotoxicity Tests, Immunologic; Dose-Response Relatio | 1995 |
Low-dose prednisolone as prophylaxis for endoscopic ileal recurrence after resection in patients with Crohn's disease.
Topics: Colitis; Crohn Disease; Endoscopy, Gastrointestinal; Follow-Up Studies; Humans; Ileitis; Ileum; Pilo | 1995 |
Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.
Topics: Adolescent; Carrier Proteins; Child; Child, Preschool; Crohn Disease; Female; Growth Disorders; Huma | 1993 |
[Diagnosis and treatment of inflammatory infiltrates of the abdominal cavity in Crohn disease].
Topics: Abdomen; Anti-Inflammatory Agents; Azathioprine; Combined Modality Therapy; Crohn Disease; Drug Ther | 1994 |
Remission following an elemental diet or prednisolone in Crohn's disease.
Topics: Adolescent; Child; Crohn Disease; Female; Food, Formulated; Growth; Hematocrit; Humans; Male; Nutrit | 1995 |
Contribution of plasma cortisol to corticosteroid-suppressed peripheral blood natural killer cell activity in Crohn's disease.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; Budesonide; Croh | 1995 |
Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children.
Topics: Adolescent; Blood Sedimentation; Child; Crohn Disease; Dietary Proteins; Enteral Nutrition; Female; | 1994 |
Mycobacterium paratuberculosis in intestinal tissue from patients with Crohn's disease demonstrated by a nested primer polymerase chain reaction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; Colitis, Ulcerative; Colon; Colonic Disea | 1994 |
Treatment of active Crohn's disease by exclusion diet.
Topics: Adult; Crohn Disease; Food Additives; Food, Formulated; Humans; Organic Chemicals; Prednisolone; Rem | 1994 |
Cyclosporin as initial treatment for Crohn's disease.
Topics: Adolescent; Biopsy; Blood Sedimentation; C-Reactive Protein; Child; Child, Preschool; Colonoscopy; C | 1994 |
Treatment of Crohn's disease by lymphocyte apheresis: a randomized controlled trial. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Topics: Adolescent; Adult; Crohn Disease; Female; France; Humans; Leukapheresis; Male; Prednisolone; Prospec | 1994 |
A comparison of budesonide with prednisolone for active Crohn's disease.
Topics: Adult; Budesonide; Crohn Disease; Delayed-Action Preparations; Double-Blind Method; Female; Glucocor | 1994 |
Home elemental enteral hyperalimentation (HEEH) for the maintenance of remission in patients with Crohn's disease.
Topics: Adult; Combined Modality Therapy; Crohn Disease; Energy Intake; Enteral Nutrition; Female; Follow-Up | 1993 |
Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Double-Blind Method; Drug Therapy, Combination; Ethambutol; | 1994 |
Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.
Topics: Acute Disease; Adult; Crohn Disease; Diet; Enteral Nutrition; Female; Humans; Male; Prednisolone; Pr | 1993 |
Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Drug Therapy, Combination; Humans; Middle Aged; Pred | 1993 |
Dietary intake and nutritional treatment in childhood Crohn's disease.
Topics: Adolescent; Child; Child, Preschool; Crohn Disease; Diet; Energy Intake; Female; Humans; Male; Predn | 1993 |
Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.
Topics: Adolescent; Adult; Aged; Crohn Disease; Female; Follow-Up Studies; Food, Formulated; Humans; Male; M | 1993 |
A controlled double blind study of azathioprine in the management of Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Double-Blind Method; | 1995 |
The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease.
Topics: Adolescent; Anti-Inflammatory Agents; Biopsy, Needle; Child; Crohn Disease; Cyclosporine; Down-Regul | 1995 |
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Topics: Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Ste | 1996 |
Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group).
Topics: Adult; Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Crohn Disease; Dietary Carbohydrat | 1996 |
Plasma arachidonic acid-rich phospholipids in Crohn's disease: response to treatment.
Topics: Acute Disease; Adult; Arachidonic Acid; Blood Sedimentation; Crohn Disease; Female; Humans; Male; Mi | 1996 |
Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Cells, Cultured; Chronic Disease; Crohn Disease; Drug Therapy, Comb | 1997 |
Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Budesonide; | 1997 |
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Crohn Disease; Female; Food, Formulated; Glucocorticoid | 1997 |
Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?
Topics: Biological Therapy; Colitis; Crohn Disease; Double-Blind Method; Escherichia coli; Humans; Intestine | 1997 |
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug | 1999 |
[Chronic inflammatory bowel diseases. Do antihistaminics reduce the need for steroids?].
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Histamine H | 2000 |
Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Budesonide; Crohn Disease; | 2001 |
Does adjuvant nutritional support diminish steroid dependency in Crohn disease?
Topics: Adult; Crohn Disease; Diet; Dietary Supplements; Dose-Response Relationship, Drug; Female; Follow-Up | 2001 |
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anus Diseases; Constriction, Pathologic; Crohn Disease; Double | 2002 |
Postoperative treatment with corticosteroids and salazosulphapyridine (Salazopyrin) after radical resection for Crohn's disease.
Topics: Adult; Clinical Trials as Topic; Crohn Disease; Drug Evaluation; Drug Therapy, Combination; Female; | 1976 |
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives.
Topics: Adult; Colonoscopy; Crohn Disease; Female; Follow-Up Studies; Humans; Male; Prednisolone; Prospectiv | 1992 |
Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease.
Topics: Chi-Square Distribution; Crohn Disease; Cyclosporins; Double-Blind Method; Drug Administration Sched | 1991 |
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.
Topics: Adult; Colon; Colonoscopy; Crohn Disease; Female; Humans; Ileum; Intestinal Mucosa; Male; Multicente | 1990 |
Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn's disease.
Topics: Adult; Clinical Trials as Topic; Colon; Crohn Disease; Female; Food, Formulated; Humans; Intestinal | 1990 |
European Cooperative Crohn's Disease Study (ECCDS): colonoscopy.
Topics: Adult; Clinical Trials as Topic; Colon; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Femal | 1985 |
[Adjuvant therapy with elemental diet in chronic inflammatory intestinal diseases. Comparative study].
Topics: Adolescent; Adult; Blood Proteins; Blood Sedimentation; Colitis, Ulcerative; Combined Modality Thera | 1986 |
[Cyclosporin A in acute Crohn disease: initial findings].
Topics: Adult; Colitis; Crohn Disease; Cyclosporins; Female; Humans; Ileitis; Male; Pilot Projects; Predniso | 1986 |
Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Crohn Disease; Female; Food Additi | 1985 |
Long-term immunosuppressive treatment in Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Clinical Trials as Topic; Crohn Disease; Female; Follow-Up Studies; | 1985 |
Controlled trial of azathioprine in Crohn's disease.
Topics: Azathioprine; Blood Cell Count; Blood Platelets; Blood Sedimentation; Clinical Trials as Topic; Croh | 1971 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid | 1972 |
A double-blind trial of azathioprine in Crohn's disease.
Topics: Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Placebos; Prednisolone; Recurrence | 1971 |
264 other studies available for prednisolone and Colitis, Granulomatous
| Article | Year |
|---|---|
Ustekinumab as the First Biological Agent for Crohn's Disease in a 10-Year-Old Girl.
Topics: Biological Factors; Child; Colonoscopy; Combined Modality Therapy; Crohn Disease; Diet, Fat-Restrict | 2021 |
Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease | 2022 |
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Topics: Adrenal Cortex Hormones; Cohort Studies; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Infla | 2022 |
Successful treatment of a patient with Takayasu's arteritis complicated with Crohn's disease with ustekinumab: A case report.
Topics: Adolescent; Crohn Disease; Female; Humans; Positron Emission Tomography Computed Tomography; Prednis | 2023 |
Successful treatment of a patient with Takayasu's arteritis complicated with Crohn's disease with ustekinumab: A case report.
Topics: Adolescent; Crohn Disease; Female; Humans; Positron Emission Tomography Computed Tomography; Prednis | 2023 |
Successful treatment of a patient with Takayasu's arteritis complicated with Crohn's disease with ustekinumab: A case report.
Topics: Adolescent; Crohn Disease; Female; Humans; Positron Emission Tomography Computed Tomography; Prednis | 2023 |
Successful treatment of a patient with Takayasu's arteritis complicated with Crohn's disease with ustekinumab: A case report.
Topics: Adolescent; Crohn Disease; Female; Humans; Positron Emission Tomography Computed Tomography; Prednis | 2023 |
Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease.
Topics: Adult; Crohn Disease; Humans; Hydrocortisone; Infliximab; Male; Prednisolone; Treatment Failure; You | 2023 |
Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease.
Topics: Adult; Crohn Disease; Humans; Hydrocortisone; Infliximab; Male; Prednisolone; Treatment Failure; You | 2023 |
Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease.
Topics: Adult; Crohn Disease; Humans; Hydrocortisone; Infliximab; Male; Prednisolone; Treatment Failure; You | 2023 |
Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn's Disease.
Topics: Adult; Crohn Disease; Humans; Hydrocortisone; Infliximab; Male; Prednisolone; Treatment Failure; You | 2023 |
Swollen fissured vulva.
Topics: Adult; Anal Canal; Anti-Inflammatory Agents; Biopsy; Colonic Polyps; Colonoscopy; Crohn Disease; Ede | 2020 |
Case of Crohn's Disease Initially Misdiagnosed as Intestinal Tuberculosis Due to Active Pulmonary Tuberculosis.
Topics: Adolescent; Anti-Inflammatory Agents; Antitubercular Agents; Colonoscopy; Crohn Disease; Diagnostic | 2021 |
Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Biomarkers; Cadherins; Cell Line; Cell Membrane Permeability; Claudins; Cro | 2021 |
Long-term retention of adalimumab treatment and associated prognostic factors for 1189 patients with Crohn's disease.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; C-Reactive Protein; Cohort Studies; Crohn Disease; Fema | 2018 |
Safe use of infliximab for the treatment of severe perianal Crohn's disease after diagnosis and treatment of lymphoma.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Gastrointestinal Agents; Humans; Infliximab; Lymphom | 2018 |
Metastatic Crohn's disease in childhood: A case report.
Topics: Child; Crohn Disease; Female; Glucocorticoids; Granuloma; Humans; Prednisolone; Skin; Skin Diseases; | 2018 |
Influence of
Topics: Adolescent; Adult; Aged; Asian People; Child; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Comb | 2018 |
Ustekinumab Rescue Therapy in a Patient With Chronic Refractory Pouchitis.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Drug R | 2018 |
Asymptomatic Macrocheilia in an Adult Woman.
Topics: Asymptomatic Diseases; Azathioprine; Biopsy, Needle; Cheilitis; Colonoscopy; Crohn Disease; Female; | 2019 |
An infiltrated vulvar plaque: Metastatic cutaneous Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Edema; Erythema; Female; Gluco | 2019 |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; A | 2019 |
[A case of drug-induced granulomatous interstitial nephritis during the long course of Crohn's disease].
Topics: Adult; Creatinine; Crohn Disease; Granulomatous Disease, Chronic; Humans; Male; Nephritis, Interstit | 2013 |
[Lip edema of unknown origin and gingival hyperplasia in an 11-year-old boy].
Topics: Abdominal Pain; Child; Crohn Disease; Diagnosis, Differential; Diarrhea; Edema; Gingival Hyperplasia | 2013 |
Maintenance of the remission stage of Crohn's disease with adalimumab therapy during pregnancy.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Blood Component Removal; Colonoscopy; Combined | 2013 |
[A case of IgG4-related sclerosing mesenteritis associated with Crohn's disease].
Topics: Anti-Inflammatory Agents; Appendix; Azathioprine; Colonoscopy; Crohn Disease; Female; Humans; Immuno | 2014 |
Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
Topics: Adolescent; Adrenal Glands; Adrenal Insufficiency; Child; Child, Preschool; Colitis, Ulcerative; Cro | 2014 |
A case of late onset-acute tubulointerstitial nephritis with infliximab and mesalazine treatment in a patient with Crohn's disease.
Topics: Adalimumab; Anti-Inflammatory Agents; Creatine; Crohn Disease; Drug Therapy, Combination; Eosinophil | 2014 |
Orofacial granulomatosis as a presenting feature of Crohn's disease.
Topics: Adolescent; Age of Onset; Crohn Disease; Feeding Behavior; Female; Granulomatosis, Orofacial; Humans | 2015 |
Paediatric anogenital Crohn's disease 11 years after Lichen planus - same background for two different entities?
Topics: Anal Canal; Azathioprine; Child; Ciprofloxacin; Crohn Disease; Drug Therapy, Combination; Female; Ge | 2016 |
Two-Year Outcomes After Exclusive Enteral Nutrition Induction Are Superior to Corticosteroids in Pediatric Crohn's Disease Treated Early with Thiopurines.
Topics: Adolescent; Child; Cohort Studies; Crohn Disease; Databases, Factual; Drug Administration Schedule; | 2015 |
Crohn's Disease in which the Patient Developed Aortitis during Treatment with Adalimumab.
Topics: Abdominal Pain; Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Aort | 2015 |
Histologically confirmed case of cerebral vasculitis associated with Crohn's disease--a case report.
Topics: Adalimumab; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biopsy; | 2015 |
Oral manifestations of Crohn's disease.
Topics: Azathioprine; Cheilitis; Crohn Disease; Glucocorticoids; Humans; Male; Oral Ulcer; Pain; Prednisolon | 2015 |
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
Topics: Acidobacteria; Actinobacteria; Adult; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Azathio | 2016 |
Vulvar inflammation: a presentation of Crohn's disease.
Topics: Adolescent; Adult; Antirheumatic Agents; Azathioprine; Biopsy; Colonoscopy; Crohn Disease; Disease P | 2017 |
Oesophageal presentation of Crohn's disease.
Topics: Azathioprine; Chest Pain; Crohn Disease; Deglutition Disorders; Endoscopy, Digestive System; Esophag | 2017 |
Does clinical response correlate with mucosal healing in patients with Crohn's disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy.
Topics: Adult; Anti-Infective Agents; Antibodies, Monoclonal; Azathioprine; Capsule Endoscopy; Cohort Studie | 2008 |
Cutaneous polyarteritis nodosa in a patient with Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Glucocort | 2008 |
Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?
Topics: Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Routes; Dr | 2008 |
Annular lichen planus in association with Crohn disease.
Topics: Anti-Inflammatory Agents; Colon; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Huma | 2008 |
Posterior reversible encephalopathy syndrome following infliximab infusion.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Brain Di | 2009 |
Cutaneous presentation of kwashiorkor due to infantile Crohn's disease.
Topics: Administration, Oral; Azathioprine; Crohn Disease; Diagnosis, Differential; Dose-Response Relationsh | 2010 |
Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Body Mass Index; Colitis, Ulcerative; Crohn Disease; Drug Ad | 2010 |
Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressi
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, R | 2010 |
Hepatocellular carcinoma occurring in a young Crohn's disease patient.
Topics: Adolescent; Adult; Age of Onset; Antibodies, Monoclonal; Azathioprine; Carcinoma, Hepatocellular; Cr | 2009 |
[Surgery, inflammatory bowel disease and biological treatment].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Crohn Disease; Hum | 2009 |
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
Topics: Acute Disease; Adult; Azathioprine; Blood Donors; Carrier State; Crohn Disease; DNA, Viral; False Ne | 2010 |
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal | 2010 |
Oedema and Crohn's disease.
Topics: Adult; Amyloidosis; Crohn Disease; Edema; Glucocorticoids; Humans; Immunosuppressive Agents; Male; M | 2010 |
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Benzazepines; Crohn Disease; Heterozygote; Humans; Ma | 2010 |
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathiopr | 2010 |
Efficacy of early treatment with infliximab in pediatric Crohn's disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Hu | 2010 |
Facial basal cell carcinoma in a young patient with Crohn disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Basal Cell; Crohn Disease; Facial Neoplasm | 2010 |
Dermatofibroma in a patient with Crohn's disease: a novel clinical manifestation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Gl | 2010 |
Internal iliac vein thrombosis in pediatric Crohn's disease.
Topics: Anticoagulants; Azathioprine; Child; Crohn Disease; Early Diagnosis; Female; Heparin; Humans; Iliac | 2011 |
Pyoderma gangrenosum requiring inpatient management: a report of 26 cases with follow up.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Colitis, Ulcerative | 2011 |
[Crohn's disease presenting with erythema nodosum as an early sign: a case report].
Topics: Adolescent; Anti-Inflammatory Agents; Azathioprine; Colonoscopy; Crohn Disease; Erythema Nodosum; Fe | 2011 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn | 2012 |
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD).
Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Body Height; Ch | 2012 |
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Colonoscopy; Combined Modality Therapy; Crohn Disease | 2012 |
Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anastomosis, Surgical; Anastomotic Leak; Anti-Inflammato | 2012 |
Serum MMPs 7-9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease.
Topics: Adolescent; alpha-Macroglobulins; Anti-Inflammatory Agents; Antibodies, Monoclonal; Blood Sedimentat | 2012 |
Vaccinating patients with inflammatory bowel disease--primum non nocere.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Colitis, Ulcerative; Crohn Di | 2012 |
Letter: Pellagra as the initial presentation of Crohn disease.
Topics: Abdominal Pain; Albumins; Anti-Infective Agents; Anti-Inflammatory Agents; Crohn Disease; Diarrhea; | 2012 |
Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Enterostomy; | 2012 |
Growth in children receiving contemporary disease specific therapy for Crohn's disease.
Topics: Adolescent; Azathioprine; Body Height; Child; Child Development; Child, Preschool; Crohn Disease; Fe | 2012 |
[Perioperative Addisonian crisis].
Topics: Addison Disease; Adrenal Cortex Function Tests; Adult; Anesthesia; Anti-Inflammatory Agents; Blood V | 2012 |
Recurrent orbital myositis as an extra-intestinal manifestation of Crohn's disease.
Topics: Anti-Inflammatory Agents; Crohn Disease; Female; Humans; Middle Aged; Orbital Myositis; Prednisolone | 2012 |
The impact of preoperative biologic therapy on anastomotic complications after surgery for Crohn's disease.
Topics: Anti-Inflammatory Agents; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; | 2012 |
Crohn's disease of the large bowel following diagnosis of chronic lymphoid leukaemia: a case report.
Topics: Aged; Anti-Inflammatory Agents; Chronic Disease; Colitis; Crohn Disease; Dietary Supplements; Humans | 2013 |
Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Biopsy; Cell Nucleus; Colitis, Ulcerative; Colon; Crohn Disease; DNA; DNA- | 2002 |
Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
Topics: Absorptiometry, Photon; Adult; Aged; Body Mass Index; Bone Density; Crohn Disease; Female; Femur; Gl | 2002 |
Road traffic accident as an iatrogenic complication of steroid treatment in Crohn's disease.
Topics: Accidents, Traffic; Adult; Crohn Disease; Glucocorticoids; Humans; Iatrogenic Disease; Male; Prednis | 2002 |
Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Diagnostic Techniques, Ophthalmological; Drug Combin | 2001 |
An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications.
Topics: Adolescent; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; A | 2002 |
[Chronic inflammatory bowel diseases. Earlier transition to immunosuppressive drugs].
Topics: Antibodies, Monoclonal; Aspirin; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agent | 2002 |
Serpiginous choroidopathy: an unusual association with Crohn's disease.
Topics: Administration, Oral; Adult; Choroid Diseases; Crohn Disease; Female; Fluorescein Angiography; Gluco | 2002 |
[Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colonoscopy; Constriction, Pathologic; Croh | 2003 |
[Acute episode].
Topics: Acute Disease; Adult; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal | 2003 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2003 |
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Crohn Disease; Cyclophosphamide; Drug Resistance; Fe | 2003 |
Allergy to topical corticosteroids in inflammatory bowel disease.
Topics: Administration, Rectal; Anti-Inflammatory Agents; Crohn Disease; Drug Hypersensitivity; Glucocortico | 2003 |
[Functional asplenia after severe varicella zoster-infection diagnosis by colour Doppler ultrasound].
Topics: Adult; Atrophy; Azathioprine; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Herpes Zo | 2003 |
CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; CD4 | 2003 |
[Acute pancreatitis associated with corticosteroid treatment in Crohn's disease].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Crohn Disease; Female; Huma | 2003 |
[Prednisolone-treated acute regional enteritis].
Topics: Crohn Disease; Prednisolone | 1962 |
ORAL BETAMETHASONE 17-VALERATE IN CHRONIC ULCERATIVE COLITIS AND CROHN'S DISEASE.
Topics: Betamethasone; Betamethasone Valerate; Colitis; Colitis, Ulcerative; Crohn Disease; Drug Therapy; En | 1965 |
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease.
Topics: Acute Disease; Adult; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Crohn Disease; | 2003 |
Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Case-Control Studies; Chemokines; Crohn Di | 2004 |
Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohńs disease.
Topics: Adolescent; Adult; Anastomosis, Surgical; Crohn Disease; Digestive System Surgical Procedures; Femal | 2003 |
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hor | 2004 |
Magnetic resonance angiography in a patient with Crohn's disease associated cerebral vasculitis.
Topics: Adult; Angiography, Digital Subtraction; Cerebral Angiography; Cerebral Infarction; Crohn Disease; D | 2004 |
[Corticodependent Crohn's disease].
Topics: Adult; Azathioprine; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Predn | 2004 |
[New research results give hope. Causal therapy of Crohn disease in sight].
Topics: Algorithms; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non- | 2004 |
[In spite of lacking abdominal complaints. Intestinal disease was diagnosed because of the lips].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cheilitis; Crohn Disease; | 2004 |
[A case of Crohn's disease with broncho-bronchiolitis].
Topics: Adult; Anti-Inflammatory Agents; Bronchiolitis; Bronchitis; Crohn Disease; Humans; Male; Mesalamine; | 2004 |
Esophagitis in an adolescent patient with Crohn's disease after changing treatment from prednisolone to budesonide.
Topics: Adolescent; Budesonide; Crohn Disease; Esophagitis; Female; Humans; Peptic Ulcer; Prednisolone; Trea | 2004 |
Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Female; Granulocytes; Humans; L | 2004 |
Coincidence or causality: celiac and Crohn diseases in a case of Turner syndrome.
Topics: Adult; Anti-Inflammatory Agents; Celiac Disease; Crohn Disease; Female; Humans; Prednisolone; Turner | 2005 |
Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; | 2005 |
[Paradigmatic shift in drug treatment of Crohn disease].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Crohn Disease; Humans | 2005 |
Cutaneous granulomatous vasculitis in metastatic Crohn's disease.
Topics: Adult; Biopsy, Needle; Crohn Disease; Female; Follow-Up Studies; Granuloma; Humans; Immunohistochemi | 2005 |
Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Colitis, Ulcerative; Complement Activat | 2005 |
Effect of systemic corticosteroid therapy on risk for intra-abdominal or pelvic abscess in non-operated Crohn's disease.
Topics: Abdominal Abscess; Administration, Oral; Adult; Anti-Inflammatory Agents; Budesonide; Confidence Int | 2005 |
Treatment of vulval Crohn's disease with infliximab.
Topics: Abdominal Wall; Adult; Antibodies, Monoclonal; Cesarean Section; Cicatrix; Crohn Disease; Drug Thera | 2006 |
Repeat planar white cell scanning to monitor short-term therapy of active inflammatory bowel disease: a methodological study and comparison with clinical scores and novel inflammatory markers.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Colitis, Ulcerative; Crohn Disease; Feces; Female; Huma | 2006 |
Corneal perforation due to severe peripheral ulcerative keratitis in Crohn disease.
Topics: Aged; Combined Modality Therapy; Conjunctiva; Corneal Ulcer; Crohn Disease; Glucocorticoids; Humans; | 2006 |
Multifocal posterior uveitis in Crohn's disease.
Topics: Adult; Coloring Agents; Crohn Disease; Electroretinography; Female; Fluorescein Angiography; Glucoco | 2007 |
[A case of Turner syndrome complicated with Crohn's disease, erythema nodosum and Hashimoto disease].
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Erythema Nodosum; Female; Hashimoto Disease; Humans; | 2006 |
Vulvar ulceration with an unexpected underlying cause.
Topics: Adult; Crohn Disease; Female; Glucocorticoids; Humans; Prednisolone; Ulcer; Vulvar Diseases | 2006 |
Serum trefoil factors in patients with inflammatory bowel disease.
Topics: Adenosine Triphosphatases; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Colitis, U | 2006 |
Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Chemokines; Crohn Disease; Cyclophosphamide; Cytokines; D | 2007 |
Intercenter variation in initial management of children with Crohn's disease.
Topics: Adolescent; Anti-Bacterial Agents; Antibodies, Monoclonal; Canada; Child; Crohn Disease; Drug Utiliz | 2007 |
Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immun | 2007 |
[Methotrexate-induced pneumonitis in a woman with Crohn's disease].
Topics: Acute Disease; Adult; Crohn Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Glu | 2007 |
Gallbladder perforation in a patient on steroid therapy.
Topics: Adult; Cholecystectomy; Crohn Disease; Gallbladder Diseases; Glucocorticoids; Humans; Male; Peritone | 2007 |
Severe Crohn disease of the lung following colectomy.
Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy; Child, Preschool; Colectomy; Cough; Crohn Disease; D | 2007 |
Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Antigens, CD; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Fema | 2008 |
Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppre | 2008 |
Current practice in management of Crohn's disease in Wales.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Attitude of Health Personnel; Col | 2008 |
[Ulcerative and granulomatous colitis].
Topics: Colitis, Ulcerative; Colonoscopy; Crohn Disease; Diagnosis, Differential; Humans; Prednisolone; Sulf | 1981 |
[An approach to the medical management of inflammatory bowel disease (author's transl)].
Topics: Azathioprine; Colitis; Colitis, Ulcerative; Crohn Disease; Humans; Parenteral Nutrition, Total; Pred | 1981 |
[Evaluation of the results of radical surgical treatment of Crohn disease as related to a diversified postoperative treatment].
Topics: Azathioprine; Crohn Disease; Follow-Up Studies; Humans; Postoperative Care; Postoperative Complicati | 1981 |
Inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Drug Combinations; Glucosamine; Human | 1982 |
Medical and surgical treatment of inflammatory bowel disease in pregnancy.
Topics: Adrenocorticotropic Hormone; Antidiarrheals; Colectomy; Colitis, Ulcerative; Crohn Disease; Diet; Fe | 1983 |
[Immunomodulation treatment of inflammatory bowel disease].
Topics: Anti-Bacterial Agents; Antibody Formation; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Co | 1984 |
Impaired semen quality in Crohn's disease--drugs, ill health, or undernutrition?
Topics: Adult; Azathioprine; Crohn Disease; Humans; Male; Middle Aged; Nutrition Disorders; Oligospermia; Pr | 1983 |
Is tube feeding with elemental diets a primary therapy of Crohn's disease?
Topics: Combined Modality Therapy; Crohn Disease; Enteral Nutrition; Food, Formulated; Humans; Prednisolone; | 1984 |
Pseudotumor of the orbit and Crohn's disease.
Topics: Adult; Crohn Disease; Drug Combinations; Female; Fibroma; Glucosamine; Humans; Ileitis; Orbital Neop | 1984 |
[Therapy of Crohn's disease].
Topics: Combined Modality Therapy; Crohn Disease; Food, Formulated; Humans; Immunosuppressive Agents; Metron | 1984 |
Angiotensin-converting enzyme in Crohn's disease and ulcerative colitis.
Topics: Adult; Colitis, Ulcerative; Colon; Crohn Disease; Female; Humans; Ileum; Male; Middle Aged; Peptidyl | 1981 |
Primary liver cell cancer occurring in association with Crohn's disease treated with prednisolone and azathioprine.
Topics: Adult; Azathioprine; Carcinoma, Hepatocellular; Crohn Disease; Female; Humans; Liver Neoplasms; Pred | 1983 |
Evaluation of indium scintigraphy in patients with active inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Evaluation Studies as Topic; Feces; Humans; Hydroxyquinolines; I | 1984 |
Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Blood Proteins; Celiac Disease; Crohn Di | 1983 |
Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
Topics: Adolescent; Adult; Biological Availability; Blood Proteins; Child; Colitis, Ulcerative; Crohn Diseas | 1983 |
Absorption of prednisolone in patients with Crohn's disease.
Topics: Administration, Oral; Adult; Crohn Disease; Female; Humans; Intestinal Absorption; Male; Middle Aged | 1983 |
Crohn's disease in a Nigerian.
Topics: Colon; Crohn Disease; Diagnosis, Differential; Humans; Ileum; Male; Middle Aged; Nigeria; Prednisolo | 1982 |
Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration.
Topics: Administration, Oral; Adult; Biological Availability; Celiac Disease; Colitis; Crohn Disease; Female | 1981 |
Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Budesonide; Crohn Disease; Dose-R | 1995 |
[Crohn's disease and tobacco consumption].
Topics: Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cann | 1995 |
[Acute relapsing pancreatitis, revealing Crohn disease, and regressing under corticotherapy].
Topics: Acute Disease; Adult; Colitis; Crohn Disease; Female; Humans; Ileitis; Pancreatitis; Prednisolone; R | 1994 |
Steroid dependency in Crohn's disease.
Topics: Crohn Disease; Humans; Prednisolone; Prospective Studies; Substance-Related Disorders | 1995 |
'Conversion' from ulcerative colitis to Crohn's disease associated with corticosteroid treatment.
Topics: Adult; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Immunocompromised Host; Long-Term Care; Ma | 1994 |
Peripheral granulocytes of patients with Crohn's disease express increased numbers of functional IgG Fc receptor I.
Topics: Adolescent; Adult; Aminosalicylic Acids; Antibodies, Monoclonal; Crohn Disease; Female; Flow Cytomet | 1993 |
Use of enteric coated prednisolone in Crohn's disease.
Topics: Adolescent; Crohn Disease; Humans; Male; Prednisolone; Tablets, Enteric-Coated | 1994 |
Budesonide for inflammatory bowel disease. Is it a magic bullet?
Topics: Budesonide; Crohn Disease; Glucocorticoids; Humans; Prednisolone; Pregnenediones | 1994 |
Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Creatinine; Crohn Disease; Enzyme-Link | 1993 |
Disseminated metastatic cutaneous Crohn's disease.
Topics: Adolescent; Crohn Disease; Humans; Male; Prednisolone; Skin; Skin Diseases; Sulfasalazine | 1993 |
Antibodies to human recombinant lipocortin-I in inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Annexin A1; Antibody Specificity; Autoantibodies; Bacterial Infectio | 1993 |
Crohn's disease associated with pancreatitis of unknown etiology: a case report.
Topics: Acute Disease; Adult; Crohn Disease; Humans; Male; Metronidazole; Pancreatitis; Parenteral Nutrition | 1993 |
Frequency of glucocorticoid resistance and dependency in Crohn's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cohort Studies; Crohn Disease; Drug Resistance; F | 1994 |
Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Female; Headache; Humans; Inflammatory Bowel Diseases; Pa | 1994 |
Diffuse jejunoileitis of Crohn's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Child; Crohn Disease; Enteritis; Female; Humans; Jej | 1993 |
Growth and clinical course of children with Crohn's disease.
Topics: Adolescent; Body Height; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Growth D | 1993 |
[Alpha-interferon therapy in Crohn's disease: initial clinical results].
Topics: Adult; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Inter | 1993 |
Does exclusion of enteral lipid assist remission in Crohn's disease?
Topics: Adult; Combined Modality Therapy; Crohn Disease; Dietary Fats; Female; Humans; Ileum; Prednisolone; | 1993 |
[Basic diet in Crohn disease. Good complement to drugs for children and adolescents].
Topics: Adolescent; Child; Crohn Disease; Female; Humans; Male; Prednisolone; Remission Induction | 1993 |
Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biomarkers; Collagen; Crohn Disease; Female; Follow-Up | 1995 |
Evaluation of fat utilization in paediatric Crohn's disease using 13C-labelled fat.
Topics: Adolescent; Breath Tests; Carbon Dioxide; Carbon Isotopes; Child; Crohn Disease; Dietary Fats; Human | 1995 |
Budesonide or prednisolone in active Crohn's disease.
Topics: Anti-Inflammatory Agents; Budesonide; Crohn Disease; Drugs, Investigational; Humans; Prednisolone; P | 1995 |
Course of pseudocholinesterase isozymes during an acute phase in Crohn's disease.
Topics: Acute Disease; Adult; Butyrylcholinesterase; C-Reactive Protein; Crohn Disease; Female; Follow-Up St | 1996 |
Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Budesonide; Crohn Disease; Female; Huma | 1996 |
Anticardiolipin antibodies in Crohn's disease associated with diabetes mellitus.
Topics: Anti-Inflammatory Agents; Antibodies, Anticardiolipin; Blood Glucose; Colitis; Crohn Disease; Diabet | 1996 |
Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Child; Crohn Disease; Drug Administration Schedul | 1997 |
Reduced bone density in patients with inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Aged; Alkaline Phosphatase; Amino Acids; Anti-Inflammatory Agents; Bo | 1997 |
Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections.
Topics: Absorptiometry, Photon; Adult; Bone Density; Case-Control Studies; Colon; Crohn Disease; Female; Fem | 1997 |
[Acute hepatitis caused by Solupred in a patient with Crohn disease].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Crohn Disease; Female; Glucocorticoids | 1997 |
Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Cyclosporine; Dose-Response Relationship, Drug; Drug Administrat | 1997 |
Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
Topics: Adolescent; Anorexia Nervosa; Anti-Inflammatory Agents; Body Composition; Body Height; Combined Moda | 1997 |
Peripheral blood lymphocyte beta 2 integrin and ICAM expression in inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation; CD11 Antigens; CD18 Antige | 1997 |
[Crohn's disease in monozygotic twins].
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Diseases in Twins; Gastrointestinal Agents; Humans; | 1998 |
Metastatic cutaneous Crohn's disease in a child.
Topics: Child; Crohn Disease; Humans; Male; Prednisolone; Skin Diseases | 1998 |
Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adolescent; Body Composition; Body Height; Body Mass Index; Bone Density; Ch | 1998 |
Activation of nuclear factor kappa B inflammatory bowel disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Blotting, Western; Colitis, Ulcerative; | 1998 |
Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Topics: Adult; Biomarkers; Blood Coagulation; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Fema | 1998 |
Bronchiectasis following colectomy for Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Bronchiectasis; Colectomy; Crohn Disease; Female; Humans; Postopera | 1998 |
Highly destructive perianal Crohn's disease.
Topics: Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Anus Diseases; Ciprofloxacin; Colostomy | 1998 |
Metastatic Crohn's disease of the lung.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bronchi; Bron | 1998 |
[Pharmacotherapeutic compass 1998].
Topics: Anti-Inflammatory Agents; Budesonide; Clinical Protocols; Colitis, Ulcerative; Crohn Disease; Guidel | 1998 |
Sweet's syndrome and erythema nodosum: the simultaneous occurrence of 2 reactive dermatoses.
Topics: Adult; Biopsy; Crohn Disease; Erythema Nodosum; Female; Humans; Leukemia, Myeloid, Acute; Male; Midd | 1999 |
A comparison of budesonide and mesalamine for active Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn D | 1999 |
The steroid resistance of Crohn's disease.
Topics: Adult; Binding Sites; Crohn Disease; Drug Resistance; Glucocorticoids; Glucose; Humans; Hydrocortiso | 1999 |
Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Dose-Response Relationship, Drug; Drug Administratio | 1999 |
[Moderate aplastic anemia associated with Crohn's disease during antithymocyte globulin treatment].
Topics: Anemia, Aplastic; Anti-Inflammatory Agents; Antilymphocyte Serum; Crohn Disease; Female; Humans; Imm | 1999 |
Hyperbaric oxygen as adjunct therapy for Crohn's intractable enteric ulcer.
Topics: Adolescent; Anti-Inflammatory Agents; Colonic Diseases; Crohn Disease; Female; Follow-Up Studies; Fo | 1999 |
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcitriol; | 2000 |
Crohn's disease of the esophagus: report of a case.
Topics: Adult; Anti-Inflammatory Agents; Crohn Disease; Esophageal Diseases; Gastrointestinal Agents; Humans | 2000 |
Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Humans; Hydrocortisone; Monocytes; Pre | 2000 |
Neovascular glaucoma as a complication of retinal vasculitis in Crohn disease.
Topics: Administration, Topical; Anti-Inflammatory Agents; Crohn Disease; Fluorescein Angiography; Fundus Oc | 2000 |
Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease.
Topics: Administration, Oral; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Therapy, Combinati | 2001 |
Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
Topics: Adult; Azathioprine; Chronic Disease; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; | 2001 |
Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.
Topics: Absorptiometry, Photon; Adult; Age Distribution; Age Factors; Aged; Anti-Inflammatory Agents; Body W | 2001 |
Mortality associated with infliximab.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Gastrointestinal Agents; Humans; | 2001 |
Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study.
Topics: Adult; Crohn Disease; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Ag | 2001 |
Tracheobronchial involvement with Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Bronchitis; Bronchoscopy; Crohn Disease; Female; Humans; Prednisolo | 2001 |
Ileal Crohn's disease is best treated by surgery.
Topics: Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Ileum; Mesalamine; Prednisolone | 2002 |
Steroid dependency in Crohn's disease.
Topics: Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Glucocorticoids; Huma | 2002 |
Chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Bile Acids and Salts; Child; Cholestyramine Resin; Colitis, Ulcerat | 1977 |
[Management and prognosis of Crohn's disease].
Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Female; Humans; Male; Prednisolone; Prognosis; Sulfa | 1977 |
[Current possibilities of treatment of nonspecific ulcerative colitis and Crohn's disease].
Topics: Blood Transfusion; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Hydrocorti | 1978 |
[Use of a chronomulticorticoid in the treatment of Crohn's disease].
Topics: Adolescent; Adult; Cortisone; Crohn Disease; Drug Therapy, Combination; Female; Humans; Male; Middle | 1979 |
Metronidazole for Crohn's disease.
Topics: Adult; Child; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hu | 1975 |
Plasmapheresis in Crohn's disease.
Topics: Adult; Antigen-Antibody Complex; Crohn Disease; Evaluation Studies as Topic; Female; Humans; Male; M | 1979 |
Genital Crohn's disease in a 6-year-old boy.
Topics: Child; Crohn Disease; Genital Diseases, Male; Humans; Inflammation; Male; Prednisolone | 1978 |
Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.
Topics: Administration, Oral; Adolescent; Adrenocortical Hyperfunction; Asthma; Biological Availability; Chi | 1978 |
Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids.
Topics: Anti-Bacterial Agents; Colitis, Ulcerative; Crohn Disease; Humans; Postoperative Complications; Pred | 1978 |
[Surgical and medical treatment of Crohn's disease (author's transl)].
Topics: Acute Disease; Azathioprine; Chronic Disease; Crohn Disease; Drug Therapy, Combination; Female; Huma | 1977 |
[Diagnosis and therapy of Crohn's disease].
Topics: Adolescent; Adult; Cortisone; Crohn Disease; Humans; Prednisolone; Sulfonamides | 1976 |
An unusual case of Crohn's disease in a West Indian child.
Topics: Adolescent; Azathioprine; Child; Crohn Disease; Female; Humans; Hypertrophy; Perineum; Prednisolone; | 1976 |
[Immunosuppressive treatment of Crohn's disease].
Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Prednisolone; Remissi | 1976 |
Split ileostomy in the treatment of Crohn's disease of the colon.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Body Weight; Crohn Disease; Female | 1975 |
Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Cataract; Child; Child, Preschool; Colitis, Ulcerative; Crohn Disease; Female; Hu | 1992 |
[Angiotensin-converting-enzyme (ACE) in Crohn's disease].
Topics: Adult; Crohn Disease; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Prednisolone; Regre | 1992 |
Cytokines and platelet-activating factor in human inflamed colonic mucosa.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anti-Idiotypic; Calcimyci | 1992 |
[Clinical study on Crohn disease].
Topics: Antibody-Dependent Cell Cytotoxicity; Crohn Disease; Cytokines; Drug Combinations; Glucosamine; Huma | 1992 |
Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Colon; Crohn Disease; Female; Humans; Intestinal Mucosa; Male; Middl | 1992 |
[Peristomal pyoderma gangrenosum after colectomy for Crohn disease. Successful medical treatment].
Topics: Aged; Colectomy; Colostomy; Crohn Disease; Female; Humans; Prednisolone; Pyoderma Gangrenosum; Surgi | 1992 |
Is elemental essential?
Topics: Crohn Disease; Diet; Enteral Nutrition; Humans; Prednisolone | 1992 |
[Clinical study on inflammatory bowel diseases].
Topics: Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Hu | 1992 |
[Crohn disease in children].
Topics: Age Factors; Azathioprine; Child; Colectomy; Crohn Disease; Female; Humans; Male; Prednisolone; Sulf | 1991 |
[Changes in cell-mediated immune reactions in Crohn's disease].
Topics: Adult; Colitis; Crohn Disease; Drug Therapy, Combination; Female; Humans; Ileitis; Immunity, Cellula | 1991 |
[Pregnancy and chronic inflammatory bowel diseases].
Topics: Birth Weight; Colitis, Ulcerative; Crohn Disease; Female; Gestational Age; Humans; Infant, Newborn; | 1991 |
Oral Crohn's disease with late intestinal manifestations.
Topics: Child; Crohn Disease; Female; Granuloma; Humans; Ileal Diseases; Mouth Diseases; Mouth Mucosa; Nose | 1991 |
Elemental diet in steroid-dependent and steroid-refractory Crohn's disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Crohn Disease; Drug Resistance; Drug Therapy, Combination; Fe | 1991 |
Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.
Topics: Administration, Oral; Body Weight; Crohn Disease; Cyclosporins; Drug Therapy, Combination; Humans; P | 1991 |
Monocyte zinc and in vitro prostaglandin E2 and interleukin-1 beta production by cultured peripheral blood monocytes in patients with Crohn's disease.
Topics: Cells, Cultured; Crohn Disease; Dinoprostone; Female; Humans; Interleukin-1; Leukocyte Count; Male; | 1991 |
Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease.
Topics: Biopsy; Colitis, Ulcerative; Colon; Crohn Disease; Humans; Prednisolone; Receptors, Interleukin-2 | 1990 |
Phospholipase activation and arachidonic acid release in intestinal epithelial cells from patients with Crohn's disease.
Topics: Adult; Arachidonic Acids; Cells, Cultured; Crohn Disease; Female; Humans; Ileitis; Intestinal Mucosa | 1990 |
Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.
Topics: Adult; Crohn Disease; Endoscopy; Humans; Ileum; Intestinal Mucosa; Middle Aged; Prednisolone | 1990 |
Anorexia nervosa complicating inflammatory bowel disease.
Topics: Adolescent; Anorexia Nervosa; Body Image; Child; Colitis, Ulcerative; Crohn Disease; Family Therapy; | 1990 |
[Fistulas in Crohn disease--conservative versus operative treatment. The internist viewpoint].
Topics: Adolescent; Adult; Child; Combined Modality Therapy; Crohn Disease; Female; Humans; Intestinal Fistu | 1985 |
Measurement of plasma prednisolone level to evaluate a prednisone treatment failure in an adolescent with Crohn's disease.
Topics: Adolescent; Body Image; Crohn Disease; Humans; Male; Patient Compliance; Prednisolone; Prednisone | 1989 |
[A case of Crohn's disease complicated with hypokalemic paralysis].
Topics: Adult; Crohn Disease; Humans; Hypokalemia; Male; Paralysis; Prednisolone | 1989 |
[Crohn disease: initial experiences with cyclosporin A in an adolescent girl].
Topics: Adolescent; Azathioprine; Crohn Disease; Cyclosporins; Female; Humans; Lymphoma; Osteoporosis; Predn | 1985 |
[Differential therapy of Crohn disease].
Topics: Combined Modality Therapy; Crohn Disease; Food, Formulated; Humans; Immunosuppressive Agents; Intest | 1985 |
Gastrocnemius myositis in a patient with inflammatory bowel disease.
Topics: Adenocarcinoma; Adult; Colectomy; Colon; Colonic Neoplasms; Crohn Disease; Female; Humans; Myositis; | 1985 |
Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
Topics: Adult; Aged; Colitis, Ulcerative; Crohn Disease; Delayed-Action Preparations; Female; Humans; Intest | 1985 |
Esophageal stricture in Crohn's disease--a case report.
Topics: Crohn Disease; Esophageal Diseases; Esophageal Stenosis; Humans; Male; Middle Aged; Prednisolone; Su | 1986 |
[Polyarteritis nodosa based on a case report].
Topics: Adult; Appendectomy; Appendicitis; Appendix; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Diagn | 1987 |
Relationships between drug regime and histology of rectal mucosa in Crohn's disease.
Topics: Crohn Disease; Humans; Intestinal Mucosa; Prednisolone; Rectum; Statistics as Topic; Sulfasalazine | 1988 |
Epidermolysis bullosa acquisita and Crohn's disease. A case report with immunological and electron microscopic studies.
Topics: Adult; Crohn Disease; Epidermolysis Bullosa; Fluorescent Antibody Technique; Humans; Immunoenzyme Te | 1988 |
[Recent progress in diagnosis and treatment of digestive diseases. III. Inflammatory bowel diseases. 7. Medical treatment of ulcerative colitis and Crohn's disease].
Topics: Adrenocorticotropic Hormone; Colitis, Ulcerative; Crohn Disease; Drug Combinations; Glucosamine; Hum | 1988 |
Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Dise | 1987 |
[Inflammatory bowel disease; internal therapy].
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Drug Combinations | 1988 |
[Treatment using lymphocytapheresis of severe forms of Crohn's disease. Preliminary results].
Topics: Adult; Consumer Behavior; Crohn Disease; Female; Humans; Killer Cells, Natural; Leukapheresis; Leuko | 1988 |
Reduced concentrations of selenium in mild Crohn's disease.
Topics: Adult; Copper; Crohn Disease; Female; Humans; Leukocytes; Male; Middle Aged; Prednisolone; Selenium; | 1988 |
Variation in lower leg growth with alternate day steroid treatment.
Topics: Anthropometry; Child; Crohn Disease; Drug Administration Schedule; Humans; Leg; Male; Prednisolone | 1988 |
Use of an intravenous steroid regimen in the treatment of acute Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Drug Therapy, Combination; Female; Humans; Hydrocortisone; I | 1986 |
[Indications for surgery from the point of view of an internist].
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Crohn Disease; Female; Humans; Injections, Intravenous | 1985 |
II. Medical treatment of inflammatory bowel disease.
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enema; Glucocorticoids; Huma | 1973 |
[Regional enteritis Crohn (author's transl)].
Topics: Adult; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Different | 1973 |
The drug therapy of ulcerative colitis and of Crohn's disease.
Topics: Adrenocorticotropic Hormone; Atropine; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diarrhea; D | 1974 |
[Crohn's disease in the colon].
Topics: Adult; Colonic Diseases; Colostomy; Crohn Disease; Diverticulitis, Colonic; Drug Therapy, Combinatio | 1974 |
Psychological management of Crohn's disease.
Topics: Adult; Aggression; Colitis, Ulcerative; Crohn Disease; Diazepam; Divorce; Female; Humans; Illegitima | 1974 |
Ankylosing spondylitis.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Arthritis, Juvenile; Arthritis, Reactive; Colitis, Ul | 1968 |
The immunoglobulin concentrations in serum and bowel secretion in patients with Crohn's disease.
Topics: Adolescent; Adult; Albumins; Crohn Disease; Female; Humans; Immunodiffusion; Immunoglobulin A; Immun | 1973 |
Corticosteroids and corticotrophin in the treatment of Crohn's disease.
Topics: Administration, Topical; Adolescent; Adrenocorticotropic Hormone; Adult; Anti-Inflammatory Agents; C | 1966 |
Urinary gonadotrophin excretion in patients with ulcerative colitis and Crohn's disease treated with A.C.T.H. and corticosteroids.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Betamethasone; Colitis, Ulcerative; Crohn Disease; F | 1966 |
Two first degree relatives with dilatation of the colon due to Crohn's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Azathioprine; Body Weight; Colectomy; Colitis, Ulcer | 1973 |
[Chronic regional enterocolitis (Crohn's disease) in juveniles].
Topics: Adolescent; Blood Transfusion; Child; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; F | 1967 |
[Azathioprine therapy in regional enteritis (Crohn's disease)].
Topics: Adult; Azathioprine; Colon, Sigmoid; Crohn Disease; Female; Humans; Ileum; Intestinal Mucosa; Intest | 1970 |
Crohn's disease with mouth involvement.
Topics: Adult; Crohn Disease; Humans; Male; Prednisolone; Stomatitis; Sulfasalazine | 1972 |
An evaluation of the rosette inhibition test in Crohn's disease.
Topics: Adolescent; Adult; Age Factors; Aged; Azathioprine; Crohn Disease; Female; Humans; Immune Adherence | 1974 |
Crohn's disease and immunosuppressive therapy.
Topics: Animals; Azathioprine; Crohn Disease; Humans; Mice; Prednisolone; Recurrence | 1972 |
Leucocyte migration inhibition with Kveim antigen in Crohn's disease.
Topics: Aged; Antigens; Cell Migration Inhibition; Colitis; Crohn Disease; Female; Humans; Leukocytes; Lymph | 1971 |
Corticosteroid therapy in Crohn's colitis.
Topics: Adolescent; Adult; Aged; Biopsy; Colectomy; Crohn Disease; Diet Therapy; Female; Humans; Male; Middl | 1971 |
Medical treatment of Crohn's disease of the colon.
Topics: Colonic Diseases; Corticosterone; Crohn Disease; Humans; Prednisolone | 1970 |
Periostitis, aseptic necrosis, and arthritis occurring in a patient with Crohn's disease.
Topics: Adult; Arthritis; Crohn Disease; Elbow Joint; Female; Femur; Humans; Humerus; Knee Joint; Osteochond | 1971 |
Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children.
Topics: Adolescent; Arthritis, Juvenile; Cataract; Child; Child, Preschool; Chloroquine; Colitis, Ulcerative | 1968 |